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i
Abstract
The desire to better understand the transmission of infectious disease in the real world has
motivated the representation of epidemic diffusion processes in the context of qualitative simulation
as a computational model on provincial and community levels. In this thesis, we have developed
both agent-based models and System Dynamics models within the context of M. Tuberculosis
(TB) transmission in Saskatchewan and a community in Saskatchewan to evaluate the efficiency of
prevention programs such as contact tracing investigation. New insights about how dynamic models
and agent-based models can assist policy development and decision making in disease control will
be generated.
Moreover, we sought to compare these two modeling approaches to gain insights in TB diffusion
in Saskatchewan as well as guidance in choosing the appropriate modeling approach for particular
problems.
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Chapter 1
Introduction
1.1 Motivation
Every year, infectious diseases cause more than 13 million deaths worldwide, with two-thirds of
them occuring among children under 5 years old [18]. The top infectious disease killers include
Human Immunodeficiency Virus (HIV), Tuberculosis (TB) and malaria [18]. At the same time, we
are imperiled by newly emerging and re-emerging infectious disease such as H1N1 (swine flu) and
H5N1 (bird flu). In the past decades, a group of distinguished infectious disease specialists have
contributed remarkable knowledge to mechanisms of infectious disease pathogenesis and diagnosis.
Despite such gains, we are still facing great challenges in early detection and in the development of
effective control programs and policies to avoid global outbreaks.
With growing computational power, modeling techniques have increasingly attracted attention
as ways of enriching understanding of the causal pathways of infectious disease and for aiding
policymakers to implement effective control strategies to prevent the spread of diseases. Compu-
tational modeling offers the ability to analyze various possibilities of disease containment and to
answer “what-if” questions. In current computational-simulation studies, two popular approaches
to epidemiological modeling are System Dynamics modeling and agent-based modeling.
System Dynamics modeling, corresponding to nonlinear differential equations (DE), is a type of
equation-based modeling which can easily express the cause-effect relationships among variables in
the complex systems. Forrester’s model of the world, one of the earliest and best known examples,
was used to explore outcomes involving different future population sizes. It used variables such
as growing pollution and consumption of natural resources, where those variables interacted via
causal links and feedback loops [14]. System Dynamics models of infectious disease spread com-
monly implement structural principles drawn from the most traditional mathematical epidemiology
models, which are aggregate in character. The classic System Dynamics model for propagation of
infectious disease is the susceptible-infectious-recovered (SIR) model, firstly developed in 1927 and
which has provided fundamental insights into the disease diffusion [1]. In such aggregate models,
individuals are aggregated into larger groups with same abstracted properties. However, there has
been a limited amount of System Dynamics modeling used at the individual level [49].
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Although aggregate modeling can offer powerful insights and has allowed the derivation of the
foundational concepts of mathematical epidemiology, there are distinct limitations associated with
aggregate modeling when the focus is upon the specifics of the interactions or social contacts through
which the infection is spreading. Spurred by increasing computer resources and the need for realistic
scenario evaluation, agent-based modeling has become increasingly popular. This reflects the fact
that it lends extra flexibility in terms of representing population as a system of interacting agents
with heterogeneous features and abilities. Social network modeling and analysis, as a complement
to agent-based modeling, takes into account the importance of contact structure – pathways of
infection spread across the associated transmission and social networks.
Both of these two modeling approaches offer some important insights into the mechanisms of
infection dynamics, but the underlying assumptions of these two simulation approaches are quite
different. In the context of infectious disease, people groups within same category (stocks in Sys-
tem Dynamics models) are assumed to be homogeneous and well-mixed, which indicates that each
individual has an equal chance to spread the disease to every other [40]. As the disease rests
purely upon contacts with infectious individuals, assuming homogeneity and perfect mixing can re-
duce accuracy in assessing intervention trade-offs and undermines the validity of the model. While
the random mixing assumption within aggregate models can be relaxed to allow for representa-
tion of distinct groups that exhibit preferential mixing, the representation of such mixing can be
cumbersome and complicated. By contrast, agent-based models (as a particularly attractive class
of individual-based models) not only can capture feedback effects but also are quite flexible in
implementing heterogeneity of individual characteristics (including history information) and for
evaluating the interaction of individuals at certain points in a network. However, agent-based mod-
els carry their own trade-offs, as they suffer from high computational cost – a substantial concern
in light of our limited time and resources, particularly when we are conducting sensitivity analysis
and other forms of model analysis. Which modeling approach is more efficient or faithful? To what
degree does the added flexibility and finer granularity of agent-based modeling really yield practical
benefits when representing realistic models? When should aggregate modeling approach be used,
and when are agent-based models more suitable? In this thesis, we carry out controlled simulations
to compare the difference between agent-based models and aggregate models in the context of M.
tuberculosis transmission. In addition to facilitating an understanding of modeling trade-offs, this
approach also aids our understanding of Tuberculosis transmission via using different methodologies
of computational modeling.
In spite of the focus on understanding the disease within modeling applications, the need for
integrating the prevention strategies and control policies into epidemiological models has long been
acknowledged. Both deterministic and stochastic models have been developed to evaluate the
impact and efficiency of different control prevention and programs for infectious disease such as
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vaccination, screening, targeted treatment and contact tracing [13, 24, 25]. In the course of TB
epidemics, although previous work has explored some theoretical aspects of different treatments
and prevention [2, 58], they lack detailed representation of the ongoing operational processes of
control programs; it is necessary to characterize the dynamics of a combination of several important
prevention strategies such as active diagnosis, treatment of Latent TB infection (TLTBI) and
contact tracing investigation. In order to provide an illustration of how dynamic models can be
used to evaluate and guide operational control strategies, we introduce a System Dynamics model
of TB transmission that explores some approaches to integrating infection dynamics with a group
of ongoing control policies, most notably contact tracing and TLTBI, across a community in the
Canadian province of Saskatchewan. Through sensitivity analysis on contact tracing speed and
priorities, our model not only advances the overall theoretical understanding of TB transmission,
but also assists in creating operational optimum prevention strategies.
Notable advances in immunology and microbiology have provided fundamental insights into the
detailed mechanism of TB infection in the past century. At the same time, epidemiological modeling
centered specifically on the dynamics of infections at the population level has profoundly enriched
our understanding of the properties of TB and prevention [1, 20]. In spite of the remarkable insights
gained from biological research and dynamic modeling, the TB incident rate is still high in certain
geographic and demographic zones. In the Canadian province of Saskatchewan, the Saskatchewan
Anti-Tuberculosis League and the Provincial TB Control program made historical inroads against
TB, but the TB incidence rate in the province remains among the highest across Canada, with
the situation remaining especially severe among Aboriginal peoples [37]. It is still challenging to
investigate the implications of various risk factors associated with dynamics of TB diffusion. To
gain insight into development of optimum intervention policies and how the risk factors and contact
structure, at an individual level, and the protocols used for contact tracing will eventually affect the
dynamics of TB, we are motivated to create an agent-based model of TB diffusion in Saskatchewan
integrated with various control strategies. Contact structure and contact tracing investigation will
be further examined in this model to capture the impact of the contact pattern and heterogeneity
on infection and how to establish practical and efficient prevention policies.
1.2 Epidemiology of Tuberculosis
In order to facilitate computational model building and enhance the understanding of the aggregate
and agent-based models examined in this thesis, we review the basics of epidemiology of Tuberculosis
as well as the prevention and control programs in Saskatchewan.
3
1.2.1 Historical Background and Epidemiological Terminology
Tuberculosis (TB), as an airborne bacterial infection caused by bacillus Mycobacterium tuberculo-
sis, is a major cause of global mortality and morbidity, especially in poor and developing countries
with limited health care resources and weak health care systems. TB has infected approximately
2 billion people worldwide, and around 10 percent of these infected people will develop active TB
in their rest of lives [45, 54]. Although it is a curable and preventable disease, it is reported that
roughly two million people die annually from TB [54]. In Canada, despite the adoption of guidelines
and prevention programs, the incidence of TB remains high in certain areas. Saskatchewan is one
of the Canadian provinces possessing a higher incidence rate of TB; however, this statistic masks
the tremendous variability in TB risk. Most notably, the large majority of cases in Saskatchewan
occur in Aboriginal peoples which include First Nations, Inuit and Me´tis.
Before proceeding, we present a brief overview of the terminologies used in the epidemiological
context and throughout the models in this study. It is worth noting that most mycobacteria TB
transmit via airborne mechanisms. Infection by mycobacteria TB does not automatically bring on
TB disease. Usually there is an incubation period before an infected individual physically develops
the current disease, and there are individual differences in latency.
• Active TB Disease. The term “Active TB” typically refers to current disease; people with
advanced disease typically feel sick and may have some known pathologies in parts of their
body (such enclosed granulomas in various organs) where the mycobacteria TB cluster.
• Pulmonary TB. M. tuberculosis most commonly affects the lungs, yielding what is known
as pulmonary Active TB, and it also can spread to other organs such as bone and brain.
Pulmonary TB can be infectious. People with pulmonary infectious TB can breathe out tiny
droplets containing mycobacteria TB when they are coughing, sneezing, singing, and even
when just talking [39]. These TB droplets remain in the air for a couple of hours, and people
who breath in these TB droplets are exposed to mycobacteria TB.
• Non-infectious active TB. Not all active TB cases are infectious, some of them are non-
infectious. These non-infectious active TB cases can be pulmonary TB or other forms of
active TB (such as TB in bone or brain). Non-infectious active TB cases can not breath out
droplets with mycobacteria TB, so they can’t transmit the disease via the air.
• Primary Progression. After acquiring TB infection through contact, a small fraction of those
infected people will develop active TB in a relatively short period of time due to ineffective
control of infection by their immune systems. This mechanism, in which the mycobacteria
evade effective control, is termed as primary progression. The mean time for primary pro-
gression varies in different studies. Since TB is a slowly growing infectious disease, commonly
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used time limits for primary progression are 2 years or 5 years [20, 50].
• Latent TB Infection. A TB infection does not instantly bring on active TB disease; typically
there is an incubation period before disease emerges. Those infected who are able to effectively
control their TB infection without developing active TB are referred as being in a state of
latent TB infection. Within the latent stage of infection, people are infected but they don’t
have symptoms and the mycobacteria persists in an immunologically-controlled state. Most of
them will remain in the latent TB infection stage for their rest of lives; only a small percentage
of them will go on to eventually develop active TB. Such reactivation can be brought on by
HIV, a combination of complex risk factors (such as age, ethnicity and smoking), interval
from infection, a weak immune system or poor health care. Theoretically speaking, in a
latently infected person, either the mycobacteria is still alive but inactive in his cells or his
immune system might completely kill the mycobacteria. However, it is currently impossible
to differentiate between them with readily available diagnostic technologies. Latent TB cases
with inactive mycobacteria can develop the disease later on in life through re-activation; on
the other hand, for those with killed mycobacteria, they can develop the disease through
re-infection.
• Reactivation. Reactivation refers to the progression to Active TB disease resulting from a
latent infection gained a relatively long time ago. Reactivation can be triggered by many of
complex risk factors such as age, ethnicity, HIV, use of immunosuppressant drugs, and weak
immune systems.
• Reinfection. When an individual remains in the latent stage, he or she can get reinfected
by another strain of mycobacteria via a mechanism often referred as reinfection. There is
significant controversy regarding the level of reinfection that occurs within the population.
Some literature estimate that 25% of the latently infected people is at risk of exogenous
re-infection [20].
Because of the complexity of Tuberculosis pathology and heterogeneity of human immune sys-
tems, some of these terminologies or mechanisms are under debate, and different variations on the
above may be used by different researchers and health care practitioners.
1.2.2 Tuberculosis Prevention and Control
TB, as a serious contagious disease, is the second largest cause of death from contagious disease
all over the world [20]. It is estimated that 30% of the world’s population is infected with TB
[56], and the incidence rate of TB in Saskatchewan is relatively higher than that in other regions
in Canada [35]. Following the recommendation provided by World Health Organization in 1997,
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the Tuberculosis Prevention and Control Unit of Health Canada have implemented guidelines in
an attempt to eliminate Tuberculosis [3]. Here, we present a list of adopted tests, prevention and
control programs which are known as effective strategies and investigation in the battle against TB.
• Bacillus Calmette-Gurin (BCG). BCG is a vaccine against Tuberculosis (TB). However, the
duration and efficiency of the protection given by BCG are not clearly known, and the esti-
mates of its protection are controversial. One study shows an efficiency of 84% for 5 years
after immunization, and the protective efficacy declines over time [19]. However, another
study shows that BCG contributes only an efficacy of 14% in reducing TB, and it appears to
be less effective among those most in need [9].
• Active TB Treatment. Normally patients with active TB are treated for 6 to 9 months unless
they are resistant to the medication. An another therapy regimen named directly-observed
treatment short-course (DOTS) has been widely adopted in Canada and worldwide due to its
efficiency in elevating compliance rates and lowering the risk of drug resistance [55].
• Treatment for Latent TB Infection (TLTBI). The target group of this therapy is recently
infected TB individuals with no current disease. If eligible for treatment, they are treated for
6 months. This treatment seeks to give protection to those infected people in the latent stage
who might possess a higher risk of developing active TB.
• Screening. The primary purpose of Screening programs is designed to detect potential infected
individuals as early as possible. In Saskatchewan, screening targets at pre-school and school
children on reserve.
• Contact Tracing Investigation. Contact tracing, as a form of target-oriented control towards
potential next-generation cases, has been used in preventing infectious disease, including
sexually transmitted disease, TB and measles. Under the context of TB control, the main
purpose of contact tracing is the early detection of infectious TB cases and recently infected
persons who may have a higher risk of developing the disease. Contact tracing focuses on
two types of persons, namely infectious TB cases and primary TB cases [43]. Contacts
are identified and located on the basis of information provided by the active TB cases via
interview.
• Mantoux Test. As part of TB investigation, a Mantoux test is used to check whether or not
a client is infected. Positive result suggests that the client is infected by mycobacteria TB,
otherwise the risk of active TB disease is ruled out. In contact tracing and screening, the
Mantoux test is used to check the status of an individual’s TB infection.
• Chest X-Ray. A chest X-Ray is one of the tests used in active TB diagnosis.
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As listed above, remarkable prevention efforts in TB control have been made to ensure prompt
detection, effective treatment and airborne precautions. Given the relatively high rate of TB
within Saskatchewan, policies and procedures for TB control should be continuously developed and
evaluated for effectiveness to yield further insight into actions effective in minimizing the risk for
TB transmission.
1.3 An Overview of Agent-based Modeling
An agent-based model (ABM), a form of computational model, is a multi-agent system composed
of a number of interacting agents in order to satisfy their goals within an environment [17]. It
often simulates in a simplified fashion of the processes that are thought to exist and operate in
the real world. The distinct feature of agent-based model is that agents are represented explicitly
to interact with one another through passing of messages or transferring of data in a network.
Agents, as discrete social actors with their own behaviors, possess the capability to react to the
computational environment. Agents are also frequently capable of moving and have the ability to
record their historic states. Given the status, history or environment of agents, agents can achieve
sophisticated behavior following a set of incorporated rules, events or strategies [17]. Conventionally,
agents possess the following properties [57]
• Autonomy. There are some built-in states within the agents which allow them to make
decisions according their current state. They are capable to learn and adapting their actions
based on experience. State charts are one of the forms used in representing their previous or
current states as well as the transitions from state to state.
• Social Ability. This term refers to the interaction among agents via some kind of agent-
communication language. In programming terms, it means agents can send messages to and
receive messages from other agents.
• Reactivity. Agents are placed in an environment, they can perceive their environment and
some other agents in their neighborhood.
• Pro-activeness. Goal-directed behaviors is another feature of agents. They frequently have
goals to pursue on their own initiative, and undertake actions so as to attain those goals.
Agent-based modeling, also known as individual-based modeling, has been used in many ap-
plication and fields, including but not limited to air traffic control, business process management,
consumer behavior investigation and diffusion of epidemics. In this thesis, we have applied agent-
based modeling techniques in representing the transmission of infectious disease. The agent-based
models in this study use agents to represent people with specific social status and different levels of
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risk in developing Tuberculosis. Different scenarios are associated with different model designs and
different representation of epidemics, resulting in different implementations of the environments in
the models, contact patterns of individuals and characteristics of agents. For example, in one sce-
nario, individuals are allocated in a specific type of network structure and infections are performed
through direct contacts and messages passing from one infectious individual to another individual
within the network. In another scenario, individuals have their own states and internal likelihood
of getting infected or developing the disease. Infection are not transmitted by direct contacts in
this design, however the risk of developing disease depends on individuals’ own status and several
global variables which capture the overall situation of the epidemics of the disease.
1.4 An Overview of System Dynamics Modeling
System Dynamics (SD) modeling is an approach to understand dynamic behaviors and mechanism
of complex systems over time, so as to better manage those systems. System Dynamics models
often incorporate elements including causal forces, time delays, feedbacks, interactions and non-
linear relationships. The heart of System Dynamics approach are feedback and causal loops which
provide a platform to capture the circular causal effects and conceptualize the structure of a com-
plex system. The complex behaviors usually arise from interactions of two types of feedback loops,
namely reinforcing (or positive feedback) loops and balancing (or negative feedback) loops [44]. Re-
inforcing loops often amplify or accelerate divergence in behavior, while balancing loops counteract
changes and tend towards balance and equilibrium. Stocks and flows are employed in illustrat-
ing the structure of a dynamic system (containing such feedback loops within their structure).
And mathematically speaking, a formal System Dynamics model is a combination of non-linear
differential equations represented via stocks and flows.
Figure 1.1: General structure of stock and flow diagramming notation [44]
Under the context of System Dynamics modeling, real world systems can be described in terms of
continuous and connected quantities (stocks and flows) within loops of causal feedback, and applica-
ble insights and model-based understanding can be examined and derived from such stock-and-flow
and causal feedback structure of the system [53]. Figure 1.1 gives a diagrammatic representation
of stocks and flows; while in terms of mathematics, the differential equation in Figure 1.1 can be
represented as equation (1.1) [44]:
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d stock(t)
dt
= Inflows(t)− outflows(t) (1.1)
In the past decades, System Dynamics modeling approach has widespread applications on many
domains such as management, economics, public policy, ecology, epidemiolgy, and so on. For the
purpose of understanding the nature of complex systems and making reasonable and sound decision,
it has been applied in solving dynamic problems arising from corporate strategy to the dynamics of
ecological system, from the supply chain management to the battle against infectious disease [44].
1.5 Thesis Statement
In this thesis, we seeks to explore the impact of heterogeneity and model architecture on TB
outcomes via comparing both aggregate and individual-based TB transmission models. In addition,
given the high TB incidence rate among First Nation people in Saskatchewan, we use both aggregate
and agent-based models to evaluate current contact tracing investigation, and to suggest more
effective contact tracing practice in TB control in Saskatchewan.
1.6 Thesis Organization
The remainder of the thesis is arranged as follows. Chapter 2 reviews related research on math-
ematical models of infectious disease, agent-based modeling, networks and epidemic models, and
effective active TB control. Chapter 3 compares an aggregate model with an agent-based model in
the context of TB diffusion with heterogeneous individuals and network structures evaluation, and
some new insights in methodological aspects are proposed. Chapter 4 presents a System Dynam-
ics TB model integrating operational TB control programs in a community of Saskatchewan. An
network-based model of TB transmission for Canadian province of Saskatchewan is developed and
simulated in Chapter 5, and a number of scenarios regarding different protocols of contact tracing
are investigated. Chapter 6 concludes summary, contribution and future work of our studies.
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Chapter 2
Literature Review
Mathematical models of disease transmission within human populations have been acknowl-
edged in helping policy makers and epidemiologists interpret epidemiological trends, understand
the dynamics of disease spread and measure the efficiency of disease prevention and control, such
as measles, HIV and other emerging infections [1].
Starting in the 1920s, susceptible-infectious-recovered (SIR) models and variants like susceptible-
exposed-infectious-recovery (SEIR) models were introduced and helped establish the foundations
of much of mathematical epidemiology. This basic SIR model consists of three compartments of
individuals who 1) are susceptible to, 2) have been infected by and are infectious with or 3) get
recovered from a particular contagious disease. An important derived quantity in the SIR model is
the force of infection which denotes the dynamic rate at which susceptible individuals are infected
[1]. Force of infection (λ), representing the “infection pressure” resulting from the interaction of
people within a population, is a function of the number of infectious people (I), the population size
(N), transmission rate (β) and mean contacts per person per unit time (c). When the population
is randomly mixed, the simplest framework treats the force of infection as λ = βc IN . Although
differences in susceptibility to infection and variation in contact patterns between heterogeneous
individuals are neglected within this simplified context, the SIR model has exerted a profound
and persistent influence on modeling of infectious diseases. In contrast to the SIR model (which
offers a description better suited infectious diseases conferring lifelong immunity, such as smallpox
and many childhood infections), other models such as the Susceptible-Infected-Susceptible (SIS)
and Susceptible-Infected-Recovered-Susceptible (SIRS) are better characterizations of infectious
diseases where repeated infections are commonly observed and long-standing immunity is not con-
ferred, such as several sexually transmitted diseases (e.g. Chlamydia, Gonorrhea), influenza, as
well as some infections with relatively rapid waning of immunity (e.g. pertussis) [15].
Some modeling studies enrich the basic model framework with heterogeneities by subdividing
subgroups, so as to generate greater and more realistic structure [16, 20, 37]. Such disaggregation
(which uses the technique of attribute-based disaggregation [36]) can be used to stratify a model
to reflect more complex hierarchy of population or to integrate personal characteristics to generate
rich dynamical behaviors. To highlight the variations in mixing patterns (e.g. people who speak the
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same birth tongue are inclined to mix more readily among themselves), a “mixing matrix” is used
to adapt the simplified formulation of the force of infection introduced above. This mixing matrix
describes contact coefficients among different groups. The Tuberculosis (TB) model in [37] has
integrated such transmission preference to express the mixing preferences of different age groups
and ethnic categories. In addition, Hassmiller’s TB model [20] with smoking impact evaluation also
stratify people into subgroups regarding smoking status and apply specific mixing patterns.
The methodology of agent-based modeling is now widely used in a variety of social science
disciplines, including psychology, public health [16], and political science. As a powerful simulation
modeling tool, a number of real-world applications (e.g. market simulation and diffusion simulation)
are developed in reproducing the natural emergent phenomena of a system (e.g. traffic jams, or a
stock market) and generating explanation for social or other observed phenomena [6]. We discuss
each of these below.
There is an upsurge of interest in using agent-based modeling to simulate markets in recent
years; one of the pioneering commercial application is the agent-based NASDAQ stock market
model [10]. In the agent-based NASDAQ model, market participants, market institutions, market
rules and their interactions are simulated in a way approximating the processes operating in the
real-world market: investor agents are capable of buying or selling shares, following a variety of
strategies from simple to complicated ones involving learning. Due to the capability of agent-based
modeling to represent the system from the perspective of heterogeneous individual behaviors and
real-world activities other than the abstract processes or averages, the NASDAQ model can simulate
the impact of changes on the financial market under different circumstances, provide warning of
unexpected outcome of new strategies in advance, and monitor behavior of agents in response to
different implemented regulations [6, 10].
Diffusion often represents the cases where people are influenced by others around them, and
it is a fundamental process observed in diverse psychological, social, and economic circumstances.
Agent-based modeling can be used to describe many diffusion phenomena in human systems, such
as product adoption and disease diffusion models. Use of agent-based modeling in health science
has gained momentum in recent years [29, 34, 38]. For the purpose of exploring the propagation of
communicable disease through a defined population, an agent-based modeling approach is proposed
and used to simulate the spread of disease in an urban environment with geographic information
system (GIS) and spacial network integration [38]. In this work, a measles outbreak, as a case study,
is implemented in the agent-based model within a closed population where interactions among
individuals are associated with places and mobility of agents are encapsulated in a transportation
network. A variety of scenarios of an outbreak are carried out in this study to answer “what-if”
questions in a simulated geographical environment.
In addition, constant network structure, through which the disease diffuses, can be well cap-
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tured in agent-based modeling techniques. In a world where persistent patterns of contact are an
important feature of many human institutions, the ability to reason about such representations
enriches our understanding of determinants of specific epidemic patterns and better captures the
intervention trade-offs. In contrast to aggregate models in which it is assumed to be safe to assume
an approximation of a “fully-mixed population”, agent-based models are flexible in simulating dis-
ease transmission on networks. Given a network structure of concern, integrating such network
representations into a model is relatively straightforward in addressing social connections and char-
acteristics [28]. A large volume of research has studied network topologies and their impact on
various processes in the spread of disease [34]. Usually the simulated network is defined in terms
of an individual’s distribution in space or the formation under which their connections are estab-
lished. Reflecting the fact that different infections are passed via different pathways, the mixing
network should be pathway specific to satisfy the context of a particular communicable disease [28].
Within a network structure used for disease diffusion, levels of susceptibility or relative risk can
be introduced for individuals according to different characteristics such as age, ethnicity or gender;
variations around some average level of rates of infection can also be applied to individuals even in
the same group. Given such incorporation at individual level, history information is typically far
easier to capture; in addition, such information can be further used in model calibration and ac-
cessed to build adaptive policies (which change based on the characteristics of the person involved)
[31].
Beyond merely stably formed network structures, some studies seek to represent networks as
emergent properties of agent movement. One study captures human movement patterns and data
(including agents, their routine movements and locations) to derive the transmission networks [47].
Stimulated and supported by increasing computational power, agent-based modeling offers par-
ticular attraction due to its ability to represent more complex behavior patterns (e.g. those de-
pending on individual history and learning) and in capturing the dynamics of real world systems
in a natural way. However, in light of the fact that traditional aggregate compartmental modeling
(such as aggregate System Dynamics modeling or other models based around differential equa-
tions) have more established history and a larger volume of past applications, much questioning
about the trade-offs involved in agent-based modeling has taken place in recent years. Sterman
et al.[40] compared agent-based models with differential equation models in the context of a SEIR
disease model. In their work, experiments involving disease diffusion are carried out within the
stochastic agent-based SEIR models and the classic SEIR model, and the implications for choice
of model types are discussed in detail. The assumption of thorough mixing and homogeneity in
classical SEIR models are relaxed in the agent-based version by integrating network topologies and
heterogeneous individuals, and the outcome of simulations demonstrated that certain dynamics or
behavior patterns that emerged in agent-based model are distinctly different from those observed
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in differential equation models. Interactions of individuals can generate network effects which even-
tually lead to significant deviations from the predicted trends in a naively parameterized aggregate
level. The model architecture also impacts how model assumptions affect our evaluation of reality
and the perceived optimality of interventions or policies. In addition, the results suggest that the
granularity and heterogeneity of individuals’ characteristics is poorly captured or analyzed in ag-
gregate models, and some dynamics involving heterogeneity are infeasible to generate or reproduce
in the naively parameterized deterministic differential equation model.
Another difference between the two model types is that, for a given scenario involving a specific
model parameterization, the stochastic agent-based model gives a distribution of outcomes while
the deterministic differential equation model generates only one trajectory to represent the epi-
demiological pattern under the “mean-field approximation” [40]. For a nonlinear system, applying
the system to the mean of a distribution can generate very different results than what is obtained
when taking the mean of the distribution resulting from applying the system to elements drawn
from the distribution. For policymakers working with non-linear systems, the averages obtained
in an aggregate deterministic model do not always provide a close approximation to the mean of
the ensemble of realizations associated with an individual-based model which eventually might lead
to a biased estimation of the real situation [6]. Capturing outcome variability in an agent-based
model offers extra flexibility in analyzing extreme cases, in the application of explicit risk prefer-
ences, and in understanding the degree of variability between cases (e.g. the degree of variability
in system results that are associated with each of a set of interventions). Another study conducted
by S. Wagar et al. compared these two modeling methodologies in a SIR model, it is found that
the population size can trigger different simulation outcomes in these two models [27]. It bears
emphasis that for small populations, continuous approximations to counts of individuals sharing
certain characteristics can lead to very different results than obtain when considering discrete indi-
viduals. (For example, if the discrete nature of infectious individuals are captured, an infection can
much more readily go extinct than if the count of infectious individuals is treated as a continuous
quantity).
After the worldwide emergence of the SARS epidemic, some epidemiologists have been aware of
the public-health importance of understanding the source of infection and transmission networks
[41]. And the process of infection tracing (contact tracing) is recognized as an integral part of
disease control programs. Most notably, contact tracing gives the possibility reaching into those
potential high risk contacts, identifying active cases among them before they spread the infection
widely, and providing treatments to those traced cases – eventually leading to lower incidence and
prevalence of disease.
Many epidemiological models are developed in investigating programs related to disease control
(such as contact tracing) to generate effective preventive measures in order to overcome a variety
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of communicable disease including STDs, HIV and some airborne infections such as SARS and Tu-
berculosis (TB). One disease model integrating a representation of contact tracing was built for a
randomly interacting population in [33]. In their work, critical thresholds principles and likelihood
of an outbreak are derived and analyzed. This work also points out that a deterministic model ap-
proximating the stochastic tracing process can be developed in investigating the dynamics of disease
diffusion from the perspective of contact tracing [33]. In contrast to depicting the tracing procedure
in terms of aggregate models, other studies emphasize the use of contact network (containing the
transmission pathways), in representing the nature of human interaction in a more accurate way
[13]. Pairwise-approximation methods and fully stochastic simulations are proposed in [13] to esti-
mate the utility of contact tracing in SIR and SIS models in terms of sexually transmitted disease
(STDs), and relationship between efficiency of contact tracing and basic reproductive ratio (R0)
of disease is observed and analyzed in the simulations. Combining computer-generated clustered
networks within the model, it is found that clustering accounts for the destruction of possible rela-
tionships and a lower requirement for contact tracing efficiency in contrasted with that predicted
[13]. In another study, two HIV transmission models with control and prevention measures are
formulated based on a differential infectivity (DI) model and a staged-progression (SP) model to
evaluate the effectiveness of contact tracing and random screening [25]. Reproductive number and
endemic equilibrium are derived in estimating the impact of different levels of intervention pro-
grams. The effectiveness of random screening and contact tracing varies between these two models
which reminds us that the underlying etiology of the disease transmission cannot be neglected when
measuring the efficiency of prevention programs. The contribution also points out the possibility
of integrating cost as another measure in such evaluation, as well as conducting comparison with
agent-based models within the same context but using different assumptions.
In addition to the objective of identifying new active cases, contact tracing investigation can
also work as a complementary tool targeting persons with recent infections but no current disease.
To reduce the risk of developing active TB especially among those within their first 2 years of
infection (who are at particular risk of progression to Active TB), a mathematical model of the TB
epidemic is used to quantify the effectiveness of treatment for early latent TB infection (TLTBI)
[58]. Positive effects of TLTBI are observed in lowering the incidence of TB and eliminating the
disease, which suggests that targeted preventive therapy for newly infected contacts through contact
tracing investigation may ultimately offer great contribution in TB control. Another TB model
including preventive treatment for Latent TB infection produces similar outcome and confirms the
effectiveness of contact tracing in decreasing the incidence rate of TB [2].
Besides the usage of traditional modeling tools (such as differential equations models) in under-
standing the disease dynamics and contact tracing program, a variety of efforts have been made in
investigating disease transmission in conjunction with contact tracing in social networks. Never-
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theless; there are many critical issues about simulating contact tracing in networks such as purely
relying on self-reported manner of personal relationships, expensive process of data collection, ide-
alized assumptions of transmission network topology, difficulty in representing the dynamics of
human interactions including breaking and forming and challenges in depicting the strength of
relationships in a network (beyond merely dichotomous categories of present or absent) [28].
For the past century, much effort has been adapted in controlling and eliminating contagious
diseases including Tuberculosis (TB), measles, HIV and so on. For TB in particular, a variety
of mathematical models have been extended and simulated to capture epidemiological trends of
TB, understand TB dynamics as well as explore various “what-if” questions to optimize the on-
going policies and prevention strategies [20, 50, 37]. To capture risk factors associated with TB,
Hassmiller has adapted one TB model in conjunction with the impact of smoking to capture the
Indian TB epidemiological context; a model with TB transmission was extended by adding smoking
status stratification via disaggregating the stages of TB progression [20]. In another study, an age-
stratified deterministic model describing TB in England and Wales since 1900 is well established
and calibrated to estimate the relative risk of primary progression, reinfection and reactivation for
people in many age groups [50]. It is found that the age and calendar year at infection have a
distinct impact on lifelong risks of developing TB. Recently, Osgood and Mohamoud et al. [37]
have extended their aggregate TB models by incorporating age as well as ethnic stratification to
fit TB data from the Canadian province of Saskatchewan and to investigate targeted intervention
strategies for high risk subgroups and their impact on lifetime TB outcome. It is observed that a
temporary elevation in incidence rate can bring notable influence on individuals’ life long risk of
TB, and it indicates the presence of system memory in the form of latently infected population.
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Chapter 3
Comparison Between Individual-based and Ag-
gregate Models under context of Tuberculosis
Transmission
Both individual-based models and aggregate models (such as the classical focus on methodology
of System Dynamics) are widely used in epidemiological modeling. In recent years, many researchers
have been interested in the pros and cons of these two modeling approaches. In this chapter, an
aggregate System Dynamics model and an individual-based model involving TB transmission with
smoking as a risk factor are compared using controlled experimental simulations, and evaluation of
these two models will be presented. This chapter is submitted and published in the Proceedings of
the 29th International Conference of the System Dynamics Society [46].
3.1 Background
A variety of epidemiological studies have found that smoking is a risk factor for lung cancer,
chronic pulmonary and cardiovascular disease. The association between smoking and Tuberculosis
is evaluated in many studies, and some evidence suggests that smoking is strongly associated with
development of Tuberculosis, mortality of TB as well as development of severe (and particularly
infectious) forms of active TB [22]. Hassmiller [20] evaluates the situation of TB transmission in
India, and provides some important insights into smoking effects on TB diffusion using a compart-
mental model. Mahamoud et al. recreated Hassmiller’s model using System Dynamics modeling
and evaluated the impact of smoking on TB diffusion in Canadian province of Saskatchewan [30].
At a population level, Mahamoud et al.’s model gives some important insights into the impact
of smoking on TB transmission in Saskatchewan. However, some important characteristics, such
as contact patterns and the diversity of individual properties, can’t be easily investigated and
simulated at an aggregate level.
Seeking to shed light on the impact of aggregation on TB model results, we sought to recre-
ate their aggregate TB model at an individual level. We then designed simulations to compare
the results of these two modeling approaches. Through this process, we aimed not only to imple-
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ment important characteristics of TB diffusion at individual level, but also to analyze the network
structure of TB diffusion and individual heterogeneity to gain more insights into dynamics of TB
transmission in Saskatchewan.
3.2 Stucture of Tuberculosis Transmission Models with Smok-
ing Impact
3.2.1 Structure of System Dynamics Model
Based on the scheme in [20], Mahamoud et al. constructed an aggregate model of TB transmission,
including smoking as a risk factor. The model reflects the characteristic stages of TB development
as well as a stratification by smoking status.
Figure 3.1: A Schematic Representation of Mahamoud et al.’s Aggregate Model of TB
Diffusion with Smoking Impact
A simplified version of the structure of Mahamoud et al.’s model is illustrated in Figure 3.1.
Stocks, depicting states or accumulations, are represented by the rectangles. Flows, which cause
changes to the stocks over time, are shown as solid arrows. Within this model, all the population
are categorized into 6 stocks distinguishing people according to both TB and smoking status (seen
in Figure 3.1): Uninfected Non-smokers (Un), Latently Infected Non-smokers (Ln), Active TB Non-
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smokers (Tn), Uninfected Smokers (Us), Latently Infected Smokers (Ls) and Active TB Smokers
(Ts). As it is typical in System Dynamics models, the changes in the stocks over time are caused by
inflows and outflows, including recruitment, death from TB or other disease, latent TB infection,
primary progression, reinfection, reactivation, natural recovery and treatment. The time unit for
the model is one year. The parameters used in the model are displayed in Table 3.1 and Table 3.2
[30].
Table 3.1: Description of the symbols and parameter settings in Mahamoud et al.’s model
[20, 30]
Parameter Description Value Unit
βc β is defined as the probability of being infected
given the exposure, and c is the average num-
ber of contacts per TB case per year. βc gives
the average number of infections an individual
with active TB (T) causes per year.
7.788 persons per year
ρ Proportion of newly infected individuals pro-
gressing to primary TB
0.05 1
λ Proportion of the new entrants into the model
who were infected prior to their entry time
0.054 1
γ Treatment rate of TB 1 per person per year
τ Rate of Natural Recovery 0.25 per person per year
d Rate of Reactivation (Progression from latent
TB to active TB due to endogenous changes)
3.125× 10−3 per person per year
e Proportion of latently infected people with
risk of exogenous reinfection
0.25 1
pi Number of new 15 years old entrants to the
model per year
720 person per year
µtbn Mortality rate from TB for non-smokers 0.037 per person per year
µn Mortality rate from other disease among non-
smokers
0.0274 per person per year
p Proportion of the population over 15 years of
age
0.66 1
Tobacco use has been an issue of concern for years, and in Northern Saskatchewan, the overall
prevalence of smoking in 2004 was 41%, compared with 28% across the province [35]. The relative
risk for smokers progressing to active TB is much higher than that for non-smokers [20]. Besides
18
those variables used in measuring the dynamics of TB spread, smoking impacts on TB transmission
are captured using a list of parameters shown in Table 3.2. Because this TB model has not been
calibrated with empirical data and some parameters are roughly estimated, it is used more for
testing and exploring differences in methodology when measuring the dynamics of TB spread in
North Saskatchewan, considering smoking as a risk factor.
Table 3.2: Smoking related parameters in Mahamoud et al.’s model [30]
Parameter Description Value
σ0 Percentage of the entering clients who are initially smoking 0.412
σ1 Relative risk imposed by smoking on the rate of new infec-
tion
1.93
σ2 Relative risk imposed by smoking on reactivation 1.53
σ3 Relative risk of primary progression given smoking 1.53
σ4 Rate ratio for smoking on the natural recovery from Active
TB
0.65
σ5 Relative risk of TB death rate given smoking exposure 1
σ6 Relative risk of becoming infected when contacting a
smoker with Active TB (compared to contacts with a non
smoker)
2
σ7 Factor by which smoking affects the treatment rate 0.8
σ8 Mixing parameter denoting the degree of disassortivity be-
tween smokers and non-smokers
0.3
σ9 Relative risk of non-TB death rate given smoking exposure 1.14
The equations for non-smoker related stocks and flows illustrated in Figure 3.1 are as follows:
λn = pβc
Tn
Nn
[σ8 + (1− σ8)Nn
N
] + pβcσ6(1− σ8)Ts
N
(3.1)
d Un
dt
= (1− σ0)(1− α)pi − λnUn − µnUn (3.2)
d Ln
dt
= (1− σ0)αpi + (1− ρ)λnUn + γTn + τTn − eρλnLn − dLn − µnLn (3.3)
d Tn
dt
= ρλnUn + eρλnLn + dLn − τTn − γTn − µnTn − µtbnTn. (3.4)
Here Nn denotes the sum of non-smokers in the population where Nn = Un + Ln + Tn, while Ns
denotes the sum of smokers where Ns = Us + Ls + Ts. N denotes the total number of individuals
in the population and N = Nn + Ns, and Rn is the rate of new infection for non-smokers. The
initial values for the stocks [30] are Un(0) = 11429, Ln(0) = 2211, and Tn(0) = 24.
The equations for smokers demonstrated in Figure 3.1 are:
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λs = σ1pσ6βc
Ts
Ns
[σ8 + (1− σ8)Ns
N
] + σ1pβc(1− σ8)Tn
N
(3.5)
d Us
dt
= σ0(1− α)pi − λsUs − σ9µnUs (3.6)
d Ls
dt
= σ0αpi + (1− σ3ρ)λsUs + σ7γTs + σ4τTs − eσ3ρλsLs − σ2dLs − σ9µnLs (3.7)
d Ts
dt
= σ3ρλsUs + eσ3ρλsLs + σ2dLs − σ4τTs − σ7γTs − σ9µnTs − σ5µtbnTs. (3.8)
Here, Us(0) = 8008, Ls(0) = 2618, and Ts(0) = 118; λs denotes the rate of new infection for
smokers, and incorporates many factors by which smoking impacts TB progression. In this model,
smokers are more susceptible to TB infection (meaning that the chance that they get infected
given exposure is higher than for non-smokers). Moreover, smokers are more likely to transmit
the disease so that (as given by σ6) the average number of infections caused by an smoker with
active TB (when surrounded by a given group of people) is twice of that by a corresponding non-
smoker when surrounded by those same people. Besides, smokers also have a relatively high risk of
developing primary progression, reactivation and reinfection. In addition, the death rate for smokers
is also higher than that for non-smokers. In Equation (3.1) and (3.5), the assortivity coefficient
σ8 is implemented to represent the interaction pattern between smokers and non-smokers. When
σ8 = 0, it indicates that all of the population is randomly mixed with each, with no distinction
made according to smoking status; however, when σ8 = 1, smokers only interact or contact with
smokers and non-smokers only mix with non-smokers. By default, σ8 = 0.3 means individuals with
same smoking status prefer mixing with those sharing their smoking behavior, but also mix with
those of different smoking status.
3.2.2 Structure of Individual-based Model
In this work, we recreated Mahamoud et al.’s model in an individual-based fashion in the AnyLogic
software package, retaining the same parameters, values, transitions rates and interactions among
the agents. Object-oriented design is applied when recreating Mahamoud et al.’s aggregate model
in AnyLogic, attributes and behaviors of each individual are identified and implemented.
Each individual’s characters and behaviors are controlled by two state charts shown in Figure 3.2.
One state chart represents individual progression of TB infection; the other is used to represent the
smoking status of each individual. In the TBStatus state chart, a self-transition from “Uninfected”
to “Uninfected” state (the same for “LatentTB” and “ActiveTB” states) represents the process of
re-entry the same state with a certain timeout. Such self-transitions help update the dynamic rates
of an particular individual. The structure clearly shows two dimensions of each individual: TB
infection status and smoking status. All the transitions are implemented using rates the same as
corresponding rates in the aggregate model. It can be observed that there are some differences in
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Figure 3.2: Structure of individual-based Mahamoud et al.’s Model of TB Diffusion with
Smoking Impact
the implementation of these two types of models. In the aggregate SD model, six stocks accumulate
and maintain the population in different categories and the inflows and outflows are used to control
the level of the stock directly. So, for each stock, the change across a period of time equals the
total inflows minus the total outflows over that period of time.
Each agent is associated with exactly one state of the TB progression state chart and one state of
the smoking status state chart. States in an individual-based model don’t accumulate a population;
they are only used to represent each individual’s state. Furthermore, transitions in individual-
based models are quite different from the flows in an aggregate SD model. All the transitions in an
individual-based model can be triggered at a certain rate, by a timeout, condition or message. Those
transition parameters can be defined differently for individual with different attributes or state, or
change over time. In the individual-based model, more attributes or status of the individual can be
easily represented just by adding additional state charts or variables. Multidimensional status of
individual can be captured without creating combinatorial combinations of compartments or stocks
for each group of individuals with same attributes.
Moreover, maintaining the distinct state charts (one for each transition) permits a ”separa-
tion of concerns” [11] that allows a modeler to more transparently understand the structure of
individual progression along a particular dimension. Finally, given such a representation, it is
quite visually clear which aspects of heterogeneity are static in character (requiring only a param-
eter), versus which are variable (requiring a state chart or variable). However, in an aggregate
model, multidimensional representation is required for both static properties and for states (chang-
ing dynamically). Adding one more attribute for the population need to subdivide the existing
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compartments stratified for the new state. Within an aggregate model associated with multiple di-
mensions of heterogeneity, the need to distinguish individuals according to both static and dynamic
attributes requires a separation of the stocks along the dimensions of these attributes. Because the
logic associated with progression of individuals along each successive dimension of heterogeneity
are all combined in a stock, it is not immediately clear which visual transitions are associated with
which type of condition. This is particularly significant in light of the disaggregation required by
both static and dynamic attributes, as it means that a user is unable to visually distinguish static
attributes of heterogeneity from dynamic ones – thereby obscuring the scope of the model. While
the rapid visual growth of the model can be somewhat ameliorated through the use of subscripting,
the use of subscripting comes with its own drawbacks. Most notably, the equations for progression
along different types of subscripts can interact to yield a large number of equations for each stock.
3.3 Methods
The individual-based model was firstly verified, and then controlled experiments were designed and
simulated. The first group of experiments varied the implementation of individual heterogeneity,
and compared the outcome with that of the aggregate SD model. The second group of experiments
focused on different topologies, with each conducting 10 simulations of the individual-based model
to study the degree of difference obtaining with the aggregate model.
3.3.1 Verification of Individual-based Baseline Model
When first considering this individual-based version of Mahamoud et al.’s model, it is likely that
it will contain bugs. Before proceeding, we sought to verify our model via making the individual-
based model comparable with the aggregate model. Given the stochastic features of the individual-
based model, we need to conduct many simulations in the individual-based model with the same
parameters value and transitions rates as those in the aggregate model to investigate whether the
results of these 2 models are the analogous. This version of the model, referred to as the “Individual-
based Baseline Model”, reflects an individual-based model which is comparable with the aggregate
model since identical values of parameters and rates, same logics and dynamic behaviors as well as
analogous results are shared.
3.3.2 Individual Heterogeneity with Respect to BCG Vaccination
BCG, as a vaccine against TB, provides protection to people. In our model, we assume that it
gives a duration of efficacy of 31 years in Saskatchewan, and the rate of people receiving BCG was
assumed to be 20% per year in this simulation. When we try to integrate BCG as an intervention
for TB in the aggregate model, since individuals are assumed to be homogeneous under the context
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of aggregate SD model, everyone administered BCG was assumed to be fully protected for a mean
time of 31 years. While in the protected state, they are assumed to experience no risk of developing
TB Infection.
Figure 3.3: BCG Implementation in the aggregate TB model
Figure 3.3 shows the simplified implementation of BCG in the aggregate model. The state
equations of implementation for BCG in the aggregate model shown in Figure 3.3 are
d U
dt
=
B
m
− kU (3.9)
dB
dt
= kU − B
m
. (3.10)
To this structure, U denotes uninfected individuals, B represents the people under BCG protec-
tion. k is the BCG rate per year, and m is the mean time of protection conferred by BCG. In the
aggregate SD model, BCG vaccination is implemented separately for smokers and non-smokers by
adding two additional stocks to represent those vaccinated who are either smokers or non-smokers.
Figure 3.4: BCG Protection Percentage Over Time
However, the assumption that individuals are fully protected for 31 years is not completely
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reasonable, some reviews shows that the efficacy of BCG wanes like many other vaccines [19].
This phenomenon is a reflection of biological understanding of the mechanisms of immune system
memory. For example, antibodies and Cytotoxic T Lymphocytes decrease over time since last
exposure (including vaccination). Moreover, in this view, individuals following vaccination are not
fully protected, although they do have a lower chance of becoming infected. Given a mean time of
protection of 31 years, we can derive a decreasing protection level from BCG. It is assumed that
the BCG protection of an individual depends on the time since he or she receives immunization.
The longer the time since that individual received the vaccine, the lower the degree of protection
received, and the higher chance that individual will be infected given exposure (although this rate
is still lower than that obtaining among those who do not receive the vaccine). In Figure 3.4, a set
of equations describing the decreasing protection of BCG is demonstrated. It shows the fractional
degree of BCG protection (y) as a function of the time since he or she was vaccinated, among those
who remain uninfected.
Equation (3.11), coming from a first-order delay, is the mathematical solution of this declining
protection level. Moreover, since the chance of developing disease among those who have BCG
developing disease is not zero, Equation (3.12) and (3.13) are used to represent their risk of getting
infected.
y = e−
1
31 t (3.11)
λn,b = (1− y)λn (3.12)
λs,b = (1− y)λs. (3.13)
Here y is the (fractional) protection conferred by BCG, λn,b denotes the rate of new infection
for the BCG-administered non-smokers remaining uninfected; λs,b denotes the corresponding rate
for smokers. Using this characterization, we extended the individual-based baseline model to im-
plement BCG protection based on the period of time since each individual was vaccinated. This
implementation is to evaluate the impact of heterogeneity of individuals on results. The “fully
vaccinated – fully susceptible” dichotomy is the widely-used and traditional representation of vac-
cination effects, this experiment sought to investigation the impact of different representations of
BCG protection on the TB outcome, and this declining protection of BCG for each individual can’t
be easily captured in an aggregate model given a population that is vaccinated at different points in
time. So the results of these two models are designed to provide some knowledge about the impact
of heterogeneity of individuals on BCG intervention of TB.
3.3.3 Memoryless vs. Non-Memoryless Reactivation
An additional experiment sought to evaluate the merits and impact of capturing the heterogeneous
individuals in their progression to Active TB via reactivation. In this experiment, we separately
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extend the individual-based baseline model. The new structure of the model is similar to that
described by Vynnycky [50], and is shown in Figure 3.5.
Figure 3.5: Revised Individual-based Model Structure with Respect to Reactivation
In this new structure, primary progression is no longer represented with a direct transition from
the uninfected state to the Active TB state. Instead, every individual is assumed to go to the latent
state following infection. After infection, the chance he or she will develop disease depends on the
rate of reinfection and reactivation. Reactivation in this model represents the progression to active
TB, which is different from that in the model of Mahamoud et al.’s. In contrast to that model, the
reactivation rate here depends on the time since he or she got infected. This reflects the fact that
empirical observations suggests that the per-year chance for an individual to develop TB disease is
relatively high for the first few years after he or she got infected, and then the chance will decrease
over time [50]. We note that the “reactivation” transition in this model conceptually represents
both primary progression (for those cases in which the progression to Active TB takes place in the
first years following infection) and what is classically thought of as reactivation.
This model implements a reactivation rate that varies with the amount of time that has elapsed
since infection. In the previously created baseline model, the reactivation rate (d) for non-smokers
is 3.125× 10−3 per year, while that for smokers (σ2d) is 4.7× 10−3 per year. Since the model time
line is 50 years, we can derive that the chance that a non-smoking or smoking individual develops
active TB via reactivation over the course of those 50 years as follows. We note that this calculation
ignores the effects of re-infection and the competing risk of non-TB induced mortality.
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Figure 3.6: Relative risk of developing Active TB reproduced from [50]
d′n = 1− e−d×50 (3.14)
= 0.1447 per 50 years (3.15)
d′s = 1− e−σ2d×50 (3.16)
= 0.2094 per 50 years. (3.17)
Figure 3.6 shows the relative risk of developing active TB since infection. According the relative
size of the rates of years 0 to 5 after infection in Figure 3.6, we assume the reactivation rate maintains
an exponential decline throughout these years. Following the approach of Vynnycky, we assume
that the relative risk will keep constant beyond 5 years since infection, remaining at a rate equal
to that of 5 years after infection.
Figure 3.7: Revised Reactivation Rate since Infection
To compare the results of two models on an equitable basis, it is important that the overall risk of
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reactivation is preserved. On the basis of this representation, we re-normalized the reactivation rate
for each year since infection by maintaining the 50-year risk identical to that in the aggregate model.
The revised reactivation rates since infection for our model are shown in Figure 3.7. That figure
only shows reactivation rates for the first 10 years since infection; as noted above, the reactivation
rate beyond 10 years since infection is equal to that of 5 years after infection. Besides the decreasing
reactivation rate since infection, we further added two attributes to each individual: their current
age and the time since he or she developed TB after infection. This require adding a few variables
and functions in the Person class. The age of each individual is initialized randomly with a uniform
distribution extending between 0 and 75 years of age.
This experiment seeks to give us some insights into the importance of capturing the heterogeneity
of individuals’ history within a model. Since the structure of the original baseline model was
extended, the results of this model are not fully comparable with that of baseline model. But the
experiments will provide us with some valuable and detailed information regarding TB transmission,
as well as insights into the trade-offs between the two modeling types.
3.3.4 Experiments with Network Structures
In an aggregate SD model, individuals within a compartment are assumed to be perfectly mixed with
each other. This means that everyone in the same compartment experiences an identical chance
to progress on to another state (such as Active TB) and an identical chance to meet another.
However, such a representation offers limited consideration of the impact of persistent connections
between those in the populations, such as those that are common as a result of family structure,
workplaces, and limited geographic mobility. In this section, we created a network representing the
whole population. Transmission of the disease is triggered by specific person-to-person interactions
among the individuals rather than via a calculation based on the mean rate of exposure of a
susceptible individual to infectious individuals. Every individual is living in an environment which
is defined by certain types of networks. Network topology refers to the layout of the connected
nodes.
In order to make the network structured model and aggregate model comparable, σ8, the degree
of assortive mixing between smokers and non-smokers, was set to be 0 in both the individual-based
and aggregate model. σ8 = 0 means smokers and non-smokers intermingle without distinction as to
smoking status. By contrast, σ8 = 1 means that individuals mix in a perfectly assortive fashion –
in other words, smokers have no contact with non-smokers and non-smokers also have no chance to
meet smokers. Furthermore, in order to maintain a stable network structure, recruitment and death
are disabled within this experiment. Although stopping the recruitment and death might lead to
an incorrect estimates of the dynamics of TB diffusion in the real-world population, comparing the
two models in the absence of such processes will still provide us with some understanding regarding
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how network structure influences TB transmission.
In order to create a networked individual-based model comparable with the aggregate model,
we needed to establish a common risk of infection. The aggregate model maintains a traditional
representation of transmission of infection, which is governed by two key parameters – β and c
(defined in Table 3.1). Because these two parameters are only used in the aggregate model when
multiplied by each other, rather than considering each in isolation, it is most convenient to consider
the product of the two, βc. This product represents the number of people that an infective person
will infect per unit time (here, per year) when surrounded by otherwise susceptible people. In
the baseline model, βc for non-smokers is 7.788 persons per year, and that for smokers (σ6βc) is
15.57 persons per year [30]. In this experimental design, we assume that the average contacts per
susceptible for smokers are the same as that for non-smokers. Based on previous work, we assume
here β roughly equals to 0.45. Then we assume that for non-smokers, βn = β = 0.45 and for
smokers βs = σ6β = 0.9. From the value of β, and for βc, we can then calculate that the average
contacts per susceptible (c) for non-smokers or smokers are around 17 persons. Under each type of
network structure, the value of β and c are set as noted above.
Following the establishment of the experimental design, we integrated network structure by
extending and revising the individual-based baseline model. The surrounding network of individ-
uals will be separately set to be random, scale-free and small world. We held the same average
connections (17 persons) per agents in the random and small world networks, but we didn’t hold
the same for scale-free network. The following subsections provides background on each of these
types of networks. In the simulated network, only TB cases can transmit the disease by sending
messages.
Random Network
Random networks were first presented by Erdo¨s and P. Re´nyi. In a random network, the probability
that two nodes are connected is assumed uniform, and each individual is connected randomly with
a given average number of connections, regardless of any consideration of spatial position or other
individual attributes [5].
In most analytically-tractable random networks, the edges and links of each individual are fixed,
which indicates that pathways of disease transmission are almost stable [28]. Lack of clustered
groups and homogeneity of individual-level network characteristics make random network models
analogous to a random-mixing aggregate model, such as the aggregate SD model presented in [28].
Understanding gained from simulations and analysis of random networks can enhance our under-
standing of the impact of network topologies on disease spread and may aid in further developing
more complex social network structures integrating heterogeneous features of individuals.
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Scale-free Network
Scale-free networks exhibit a degree distribution following a power law. In reality, many em-
pirically observed networks appears to be approximately scale-free; examples include e-mail net-
works,Internet networks and the structure of software modules [23]. Scale-free networks are far
from homogeneous, as some individuals have a lot of connections, while most individuals are as-
sociated with relatively few connections. Compared with random networks, scale-free networks
exhibit wider ranges of heterogeneous connections. In order to capture some complex features of
disease spread, it is necessary to incorporate such super-spreaders with larger number of links into
the network [28].
Since scale-free network can display heterogeneity in terms of the number of contacts, individuals
with many connections not only possess high risk of becoming infected (due to many pathways
and links with people), but can also transmit the infection broadly once they are infectious TB
cases. Such effects can, for example, allow an infection to remain endemic in subgroups of a
broader population, even when the population average rates of contact would be insufficient to
maintain that network. Capturing this phenomenon is of great interest to both modelers and
epidemiologists, as effective disease control policy and prevention programs can be enabled when
the dynamics of infection in the network and behaviors of these concentrated high risk individuals
are well understood.
Small World Network
A small world network is type of network topology within which each individual is connected with a
given number of nearby individuals, but there are some larger-range connections. In another words,
small world networks integrate both locality of connections among individuals (which add the fact
that two connected individuals are likely to share additional connections) and some long-range links
through which transmission events can be performed [28]. Such highly clustered connections can
exhibit the spread of infection locally, while the long-range pathways can depict the transmission
phenomenon that epidemic spread is rapid and unlikely to be constrained within small regions of
the population [52].
3.4 Results
In this section, the results of experiments will be presented and analyzed.
3.4.1 Individual-based Baseline Model
Since this individual-based (or agent-based) model is a stochastic one, we simulate this baseline
model for 100 runs to verify that it yields results comparable to those associated with the aggregate
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(or System Dynamics) model. The results suggest that the differences between these two models
are small and can be explained by stochastic factors, seen in Table 3.3 and Figure 3.8. The bigger
discrepancy of Tn and Ts are due to stochastic factors because of small size of population in these
two categories. Jacquez and Simon have proved that small populations are highly affected by
stochasticity [26]. However, the difference will practically disappear when the population in these
stocks is above 100. The relative discrepancy for Un, Us, Ln and Ls stocks/states is quite small,
and is likely due to stochastic effects.
Table 3.3: Stocks/States of System Dynamics Model(SDM) and of Agent-based Baseline
Model(ABM) at 50th Year
Stock/State SDM Results ABM Mean ABM Std.
Deviation
Minimum Maximum
Un 8415 8443.04 213.1 7955 8925
Ln 6536 6504.52 182.4 5998 6904
Tn 23.54 23.83 5.3 11 44
Us 2664 2693.48 132.8 2334 3062
Ls 5981 5943.39 132.9 5612 6308
Ts 49.35 49.25 7.4 32 78
Total Pop. 23668.9 23657.51 148.5 23301 24043
Figure 3.8 shows the baseline trajactories for all the stocks/states of both System Dynamics
model and agent-based baseline models. The black lines show the population size in each stock
over time, while the red ones are the results from agent-based baseline model. The behavior of the
agent-based baseline model over time is quite consistent with that of aggregate System Dynamics
(SD) model.
This comparison reflects the fact that the aggregate SD model is a continuous deterministic
model which gives a single outcome, while the individual-based based model is constructed from
quantized individuals and yields a distribution of outcomes. The need to perform an “ensemble”
including multiple simulations (“realizations”) in order to gain a sense of the range of model behavior
further worsens the heavy computational cost of individual-based models.
3.4.2 Evaluation of Heterogeneity through BCG Vaccination
Now we analyze the difference between individual-based models and aggregate models under the
scenario of BCG Vaccination and waning immunity.
Figure 3.9 shows the scenario results coming from both of these two models. The black lines rep-
resent the results coming from the aggregate SD model, while the red lines represent the simulation
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Figure 3.8: Comparison of System Dynamics Model and Agent-based Baseline Model
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results coming from individual-based models. As noted in the methods section, each individual-
based simulation was simulated for 10 realizations. Because of stochastic factors, the results of each
simulation in the individual-based model are different from one another.
Figure 3.9: Prevalence of TB Infection and Active TB Given BCG Administration in
Agent-based Model and Aggregate Model
For non-smokers, we can observe that representing a continuously waning protection from BCG
can produce a higher prevalence of latent TB infection compared to that resulting from use of a
dichotomous protected/not protected distinction. For example, in the 50th years, the prevalence of
latent TB infection in the individual-based model is almost three times higher than that in aggregate
SD model. Similarly, the prevalence of active TB is also higher in the individual-based model when
it is compared with that against an aggregate model. The situation for smokers displays a similar
pattern to that obtaining among non-smokers. It is worth emphasizing that these differences in
rates emerge in spite of the fact that the decay rates in the individual-level model (on the one hand)
and aggregate model (on the other) are identical.
In conclusion, the patterns of TB transmission resulting from the assumption of dichotomous
waning BCG protection and continuously waning BCG protection over time are quite different.
This gives some insights into the difference between these two models. It is possible to capture
the heterogeneity of individuals in aggregate models by developing several compartments, each
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representing a different level of decayed immunity. However, such a representation is awkward and
cumbersome, particularly when there are several other dimensions of heterogeneity present. By
contrast, individual-based models can easily capture the heterogeneous attributes of each individual.
From this point of view, individual-based models can represent the different attributes or status of
individuals more straightforward than aggregate models.
The experiment on BCG protection shows that two theories of BCG protection duration produce
distinct results, and many studies suggested that vaccines (including BCG) confer a decreasing
protection over time. Given the divergence in results, it would appear that the representation
of dichotomous susceptibility in the aggregate model represents too extreme a simplification of
individual-level dynamics to adequately support investigation of intervention trade-offs.
3.4.3 Evaluation of Memoryful Reactivation
Next, we consider the difference between individual-based models and aggregate models associated
with the degree of memory associated with the reactivation process. While many runs of this
scenario have been conducted, only one of them is presented here as an example to exhibit the
findings.
In this experiment, the aggregate model assumes a memoryless progression from latent TB
infection to Active TB. By contrast, individuals in the agent-based model exhibit a decreasing
reactivation rate with rising time since infection. The analysis of time from latent infection to
active TB and age structure is important, as it might give some insights into the prevention of
TB. Age, often considered as a confounder, can be examined in the individual-based model; among
other benefits, such an examination can aid us in finding high risk age groups of individuals who
are more susceptible to TB infection. The accessibility of this information within the model could
also permit evaluation of policies which explicitly consider the estimated time since an individual’s
exposure when providing prophylactic treatment.
Figure 3.10 and Figure 3.11 show the time from latent infection to initiation of active TB for
both smokers and non-smokers. In these two graphs, it is found that people are more likely develop
TB in the first two years after infection. The proportion of TB cases developing TB within the two
years following infection is 61% for non-smokers and 55% for smokers.
It is notable that in an aggregate model, it is currently difficult to derive this important
individual-level history information in the context of time-varying risks (e.g. associated with reinfec-
tion, or due to changes due in delivery of prophylaxis). Moreover, we also have estimated historical
data about the interval from latent infection to TB in Saskatchewan. Using the individual-based
model provides us the opportunity to use this historical information to calibrate our model and
gain confidence that it captures the essentials of TB transmission in Saskatchewan. Table 3.4 de-
picts a comparison of agent-based modeling results with historical information from Saskatchewan
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Figure 3.10: Interval from Latent to Active TB for non-smokers
Figure 3.11: Interval from Latent to Active TB for smokers
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Anti-TB League Report [42].
In Table 3.4, although the results of agent-based model are not perfectly consistent with the
historic data, parts of results from agent-based model display some consistency. For example, the
Interval from 0.5 to 1 year and 1 to 2 year for estimated results in agent-based model are roughly
consistent with that for non-Indian in 1972. Furthermore, age is also captured in the agent-based
model for this experiment.
Table 3.4: Comparison between historical information and estimated results of AB model
Interval From
Latent to TB
Cumulative Per-
centage in AB
Model (%)
Cumulative Per-
centage in 1972 for
Non-Indian (%)
Cumulative Per-
centage in 1972
for Indian (%)
<0.5 year 20.6 31.8 36.4
0.5-1 year 40.0 42.1 50
1-2 years 56.29 52.6 63.6
2-3 years 61.87 78.9 68.2
3-4 year 65.81 84.2 72.2
4-5 year 67.91 89.5 86.4
5-6 year 69.73 - 90.9
6-7 year 71.66 - 95.5
7-8 year 73.55 - 100
8-9 year 74.94 - 100
>9 year 100 100 100
Figure 3.12 shows the age structure of TB cases for both smokers and non-smokers. As exhib-
ited in Figure 3.12, we can find that non-smokers with age between 55 to 59 account for highest
percentage over all the non-smoker TB cases; while smokers within age range (40-44) and (70-74)
possess higher percentage over all the smoker TB cases. However, in contrast to the situation for
a larger model we have described in the literature [37], we note that our current model does not
capture the higher risk of infection and primary progression for the youngest age categories, so the
data shown exhibits significant discrepancies from the historically observed distribution of cases by
age.
The implementation of age in this experiment underscores the possibility of capturing age dis-
tribution among TB cases. By integrating the real age structure of the population in Saskatchewan,
such information can be valuable especially when we calibrate our model with Saskatchewan data
on age-specific case rates.
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Figure 3.12: Age Structure of non-smoker TB Cases and smoker TB Cases
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3.4.4 Evaluation of Network Structure on TB Transmission
Within this section, we examine the impact on infection burden of assuming three alternative
types of network structure, namely random, scale-free and small world. In order to make them
comparable, the average contacts in each network structure are preserved. Here we compare the
prevalence of the infection in the individual-based model and the aggregate model after simulating
the individual-based model for 10 realizations.
Figure 3.13: Fractional Prevalence of Infection of Non-smokers Under Alternative Network
Topology in Agent-based Model and Aggregrate SD Model
In Figure 3.13, we readily find that, among the non-smokers, the random network yields similar
results in the aggregate SD model. By contrast, for the scale-free and small world networks, the
prevalence of infection is lower than that in the aggregate model. The prevalence of infection in a
small world network is even lower than that in the scale-free network. In Figure 3.14, a random
network produces a lower prevalence of latent TB infection among smokers than that emerging from
the aggregate model. The prevalence of TB infection among smokers in scale-free and small world
network topologies is much lower than that in random network. The scale-free network produces
the lowest prevalence of TB infection among latent TB and active TB for smokers.
From these network experiments, small world network structure and scale free networks exhibit
a lower level of infection prevalence, while the random topology gives highest prevalence of TB
infection and Active TB for both smokers and non-smokers. In conclusion, even when maintaining
a fixed mean rate of connections, making different assumptions concerning the network types yields a
noticeable impact on TB transmission, which should not be overlooked. However the representation
in the aggregate model assumes that individuals in the same compartment are perfectly mixed with
each other. Based on the results with different types of network, we can conclude that the aggregate
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Figure 3.14: Fractional Prevalence of Infection of Smokers Under Alternative Network
Topology in Agent-based Model and Aggregrate SD Model
model runs the risk of overestimating the burden of infection in the population. From this point
of view, the details of elements left implicit in aggregate models (such as network structure) can
have a major impact upon model results, and can make a naive parameterized (and uncalibrated)
aggregate model diverge in pronounced ways from actual behavior. It is known that social networks
are sometimes well approximated by specific network types, such as scale-free or small world. The
explicit representation of different network types in an individual-based model can help us produce
a more realistic model of the real pattern of network of individuals in TB transmission.
3.5 Discussion
After running large volumes of experimental scenarios, network topology and individual hetero-
geneity are demonstrated to have a significant impact on the dynamics. Based on the conducted
comparison between the aggregate and individual-level approaches, which one is better? In reality,
we often meet trade-offs between these two modeling approaches. Based on our own experience in
modeling the TB transmission in an individual-based level and comparing the difference between
these two models, we conclude with comments on the trade-offs between these two methods.
Working at the granularity of individuals, individual-based models can more readily capture
diverse attributes of individuals and more flexibly represent more complex processes. In the ex-
periments for BCG and reactivation, individual-based models can easily record and simulate the
impact of decreasing BCG protection duration, decreasing reactivation rate over time, the interval
between latent and active TB, and age structure.
From the ease of model extension and creation, individual-based models can be extended easier
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to capture additional components of heterogeneity. When we implement the age structure of each
individual, we only need add one more variable associated with a person to represent this status.
By contrast, in an aggregate model, the modeler need to modify stocks and flow definitions across
the model. Especially when a modeler seeks to implement more attributes, even static attributes
(such as gender), the number of compartments in the stocks required rises geometrically; particu-
larly when the attributes (such as age or time since infection) are dynamic, this can lead to very
complex, intermixed formulas for flows. From this angle, individual-based models are easier to
create and more flexible to extend. In addition, the representation of waning of immunity (or other
transitions with a similar fashion) can be quite awkward in an aggregate model, since a group of
compartments exhibiting different level of declined immunity need to be created. This can be par-
ticularly cumbersome when the population represented in the aggregate model already has many
attributes (such as age group, ethnicity and gender). For example, suppose we want to implement
such waning of immunity with 10 decayed levels in an aggregate model with many attributes, 10
compartments under each element of each attribute need to be created, which can end up yielding
a huge number of stocks.
Moreover, such a representation exhibits poor separation of concerns [11]: the logic needed
to achieve progression along this dimension of heterogeneity frequently becomes tangled with the
logic associated with progression along other dynamic dimensions of heterogeneity (e.g. age). By
contrast, representation of such waning phenomenon in an agent-based model is much easier, it can
be accomplished via implementing one more function in the person class instead of adding a large
number of compartments.
From the point of view of computational resource demand and speed, individual-based models
are typically less effective – and frequently far less effective – than aggregate models; however,
sometimes it is worth while to simulate individual-based models to gain richer understanding of
the system behaviors given the detailed level of information obtained in such models. Individual-
based models can be time-consuming; for example it takes around 6 hours to run 10 simulations
on around 40,000 individuals in our experiment. But the simulation time for aggregate models are
quite short, and can almost be ignored. The simulated population size has a significant impact on
the computational trade-offs. When we double the simulated population, the time cost for aggregate
models doesn’t grow at all; however, the time and memory consumption of the individual-based
models grows at least linearly with the population (and potentially non-linearly, depending on
memory hierarchy effects, network density, and other considerations). If we want to simulate
a larger population, the performance of individual-based models is a big concern. In addition,
individual-based models, compared with deterministic aggregate models, require more time to verify
its correctness due to its stochasticity and the poor expressiveness of general purpose programming
languages exhibit when compared to the domain-specific languages commonly used by System
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Dynamics packages. Since we have limited resources and time, this can further limit our ability in
conducting more sensitivity analysis, interactive model exploration, and additional experiments. Of
particular note here is heterogeneity associated with individual history. Looking across pathogens,
such history information (such as the duration of time since a contact of a case was exposed, or
the history of Active TB in a person) can be of considerable interest when designing interventions.
Moreover, such information provides an important source of model-generated data to compare
with empirical data during calibration and model validation. While rich history information is
readily collected within an individual-based model, it is typically infeasible to maintain more than
a modicum of historical information in an aggregate model. This limitation constraints a modeler’s
options for calibration, as well as the types of interventions that can be investigated.
Networks have an important role in shaping our understanding of infectious disease. The fo-
cus on individual-level interactions within a network, rather than the population level dynamics,
attempts to address the vitally important processes of the actual infection and disease diffusion.
Through the implementation of networks, individual-based models can simulate and exhibit the
association of transmission of infection and the presence of long-term relationships between in-
dividuals more realistic, and their position within the network. By contrast, aggregate models
typically operate under the idealized mixing assumption which might overlook important patterns
of TB diffusion. Scenarios with three types of network topologies suggest that small differences
in the structure of the network can lead to significant changes in epidemic behaviors which can
eventually alter the aggregate spread of infection. In addition, taking network topologies into ac-
count allows us to more accurately capture and model several important preventions, including
contact tracing, screening program or vaccine; and more sophisticated control policies and different
strategies can be tested or simulated in a virtual environment with use of network modeling tools.
We particularly note the potential for individual-based models to evaluate policies and protocols
which take into account features of the case-contact network collected by contact tracing. How-
ever, the need to represent networks – as opposed to mixing matrices – does typically demand that
creators of individual-based models offer hypotheses about a range of details that can be conve-
niently omitted from an aggregate model. A mixing matrix in an aggregate model can readily be
created from partial network data, without a need to reason about the driving factors (in the form
of movement patterns or an encompassing network) underlying that contact data. By contrast,
reasoning about infection spread across a network on which partial data is available requires that
an individual model posit hypotheses regarding the structure of the remaining network. Similarly,
in an individual-based model in which contacts are driven by movement patterns, it may be neces-
sary to broaden the model to consider the structure of – and even the driving factors governing –
those movement patterns. Such considerations typically need not be considered when building an
aggregate model.
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The three types of networks discussed here are static – the links between the individuals don’t
change over time; as a result, the intuitive human relationships elements of breaking and forming
new connections are not currently represented. The dynamics of networks are believed to be impor-
tant in understanding the spread of some pathogens [32]. Designing networks allowing for changes
of connections over time is an ongoing challenge. However some pioneering work in tracking the
movement and behavior of individuals in real time using mobile device and GPS to collect contact
information between individuals allows approximating more comprehensive network structure and
more accurate simulation of the spread of pathogens across a population [12, 21, 28, 32].
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Chapter 4
A System Dynamics Model of Tuberculosis Dif-
fusion With Respect to Contact Tracing on Com-
munity 1
This chapter describes a preliminary dynamic model to evaluate the role of current contact
tracing policies in managing TB transmission. Through a novel representation of contact trac-
ing dynamics, the model supports investigation of how TB outcomes are affected by changes to
the breadth and timeliness of contact investigation. This chapter is submitted and accepted for
publication as a full paper in Proceedings of the 2011 Winter Simulation Conference December
2011.
4.1 Background and TB Control Activities in Saskatchewan
The difficulty of studying the application-oriented complex systems with use of traditional epi-
demiological tools was recognized for a long time. In recent decades, System Dynamics modeling
and related compartment models have been used as a complement to resolve some challenges in
infectious disease control. Dynamic modeling has shaped our understanding of the internal linkages
between causal factors and system feedback, interpreted epidemiological patterns and trends, and
informed us in policy design and evaluation at a practical level. The complexity and variability of
policy related issues accompanying the dynamics of infectious disease make applications of system
dynamics modeling a powerful and promising tool in investigating some important transmission
patterns and analyzing the trade-offs of diverse intervention programs.
Tuberculosis (TB) is a communicable disease which drains public health systems. Health rep-
resentatives in many countries plan and organize diverse control and prevention programs to fight
against the disease. The process of contact tracing investigation (CTI) serves a key function in
many TB control programs in developed countries.
In the Canadian province of Saskatchewan, most of the TB cases occur among First Nations
people (one of Canada’s Aboriginal people). They are found to suffer from a high prevalence
of TB infections. Saskatchewan health organizations have conducted many prevention programs
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to control its diffusion; such TB control activities include screening, lab investigation, contact
tracing and treatment. The contact tracing program, in particular, works as an epidemiological
tool in finding potential cases, sources of infection and latently infected contacts with a high risk
of developing TB in their lifetime.
In this chapter, we will adapt a System Dynamics model to investigate the effectiveness of the
contact tracing policies in community 1 which locates in Saskatchewan. Our model extends existing
mathematical models of TB dynamics (including the classic SIR model[1] and Osgood et al.[37]) to
capture the dynamics of TB in the context of a community as well as to estimate the efficiency of
the current contact tracing program.
To improve the quality and efficiency of disease control, sensitivity analysis can be conducted
to sort through alternatives and to assist the decision making process in identifying the best choice
with which to serve both financial constraints as well as objectives of intervention programs. We
present and discuss two modeling questions to illustrate how System Dynamics models could be used
to support and improve the development of control policies, contact tracing investigation strategy
in particular. With respect to efficiency of contact tracing, our first question aims at exploring
the efficiency in terms of investigating fraction of the contacts. This paper also seeks to explore
the benefits conferred by speeding up the contact tracing investigation procedure. More detailed
explanation regarding these two questions is demonstrated in Section 4.4. The experimental results
are presented in Section 4.5. Section 4.6 discusses model findings and summarizes our work.
4.2 Contact Tracing Objectives and Procedure in Commu-
nity 1
The main objective of contact tracing is to find latently infected people, and active TB cases –
especially infectious ones. Contact tracing investigation in Saskatchewan targets at two types of
person, namely those with infectious TB and primary TB [43]. Infectious TB cases are transmitters
of the infection; people who come in contact with infectious active TB cases can be infected. Tracing
infectious TB cases can eventually help find more infected persons with high risk of developing TB
in their lifetime. Providing treatment for latently infected people can lower their risk of developing
active TB and stop the potential pathways of TB transmission. The term “reverse contact tracing”
describes the investigation of primary TB cases who are recently infected [43]. Since contacts of
primary TB cases can be sources of TB infection, infectious TB cases are the main targeted group
in this case [43].
Within Saskatchewan, contact tracing focuses on all the contacts within 30 days of diagnosis of
the active TB case. A contact list is created and ordered from the greatest to the least amount of
exposure time [43]. It includes the following:
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• Household members: it involves family members and babysitters who live with the client in
the same house. Children have the highest priority for contact tracing, and then any family
member who has breathed the same indoor air with the client for at least 10 hours within the
past month prior to the diagnosis.
• Immediate family members who do not live with the client in the same house.
• First generation biological relatives, including aunts, uncles and cousins, etc.
• Family or friends who are current or past TB cases.
• Current or past active TB cases in the community, and those who have contacts with them.
• People from public places including schools, restaurants, bars, work and so on.
• Relatives by marriage: aunts, uncles, cousins, nieces and nephews.
• Hospitals and special care homes.
• People who ride in the same vehicle repeatedly (taxi, car, bus, school bus).
• Visitors.
4.3 System Dynamics Model of Tuberculosis Transmission
in Community 1
We have developed System Dynamics model of TB transmission to reflect the community 1 context
and contact tracing investigation. In this model, we assume that the population changes only via
birth or death, since the data regarding the mobility of the population in Community 1 is limited.
4.3.1 Structure of System Dynamics Model
The structure of our model is illustrated by stocks and flows in Figure 4.1. Our model consists
of eleven stocks. Of these eleven stocks, ten represent the population, distinguishing individuals
according to TB-specific health status and status with respect to contact tracing. The remaining
stock named “Named By TB Cases for Investigation (Cv) represents a name list of contacts to
be investigated via contact tracing. It is worth emphasizing that this stock does not represent on
segment of the population collectively represented the other stocks. There are no individuals in
this stock - rather, the stock holds a list of names of the contacts which are obtained from those
traced active TB cases. The named individuals are assumed to reside in one of the other 10 stocks.
Transitions depicted by flows in the upper part of the diagram reflect the pathways through which
people’s health and contact tracing status can progress over time.
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Figure 4.1: Structure of TB Model With Respect to Contact Tracing
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According to Figure 4.1, Susceptible people are divided into “Susceptible Non-Investigated
Pop.(Sn)” and “Susceptible Investigated Pop.(Sv)”. Similar categorizing patterns have also been
applied on infected people with no current disease. Here, the “investigated” designation denotes
those for whom we have a record of their TB infection status, while “Non-Investigated” represent
people who might be uninfected, infected or active TB cases, but where those authorities do not
know their TB infection status. The investigation process is accomplished via a contact tracing
program and is supported use of the Mantoux skin test to test whether an individual is infected
by TB. Individuals who are susceptible whether investigated or not - can acquire TB infection by
contact with an infectious cases; once infected, they will move into the “Infected Non-Investigated
Pop.(En)” stock via latent infection or “Undiagnosed and Noninfectious Active TB (Un)” via pri-
mary progression. After acquiring TB infection, those previously investigated susceptible people are
no longer considered investigated, since their TB infection status has been changed and we cannot
recognize these newly updated TB status unless they are investigated another time. Suppose a per-
son is traced and found to be Mantoux negative; he will then stay in the “Susceptible Investigated
Pop.(Sv)” stock. If this person is subsequently infected and becomes a latent TB case, he will go
to the “Infected Non-Investigated Pop.(En)” stock. The reason why his investigation status goes
to Non-Investigated is that, his current Mantoux test result – which following infection should be
Mantoux positive – is as yet unknown to those performing contact tracing. His investigation status
will not be updated to investigated unless he is traced and tested for a second time.
People in “Infected Non-Investigated Pop.(En)” can either move into “Infected Investigated
Pop.(Ev)” via contact tracing, or progress to the active TB disease state. Those infected and
investigated people have a chance to undergo a prophylactic treatment (treatment for latent TB
infection) for 6 months to lower their risk of progression to active TB disease. Not every infected
and investigated individual can get TLTBI, because the eligibility of TLTBI is restricted by certain
criteria, including those considering age, health status, history of Active TB and so on. The “Un-
der Treatment for Latent TB Infection (Lv)” and “Infected Investigated Pop Previously Received
TLTBI (Pv)” stocks characterize those traced infected people who are currently under the treat-
ment for latent TB infection (TLTBI) and those who have finished their prophylactic treatment
and are currently under certain protection from developing disease. The proportion of protected
population with TLTBI at risk of developping active TB is 0.32 [37].
People can progress to active TB via either primary progression or reactivation. In our model,
we distinguish people with active TB disease into 4 stocks according to their diagnosis status and
TB infectiousness, namely “Undiagnosed and Noninfectious Active TB (Un)”, “Undiagnosed and
Infectious Active TB (In)”, “Noninfectious TB Cases Under Treatment (Tu)” and “Infectious TB
Cases Under Treatment (Ti)”. Those undiagnosed noninfectious TB cases might develop infec-
tiousness within a period of time if they are not diagnosed. It is worth emphasizing that both
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passive and active diagnosis methods are implemented in our model to highlight the role of contact
tracing in identifying active TB cases, particularly those with the infectious form of active TB.
After recovery from either the infectious TB state or the noninfectious TB state, they will return
to the “Infected Investigated population stock because authorities will know that their Mantoux
test results remain positive.
The stock “Named by TB Cases for Investigation (Cv)” represents the number of contacts that
are queued for tracing and testing. Contacts who are named within this stock will be found to be
infected investigated people (Mantoux Positive with no current disease), Susceptible investigated
people (Mantoux Negative) or active TB cases through active diagnosis.
Every year, a number of infectious or noninfectious TB cases will be diagnosed. Those diagnosed
as infectious TB cases will be traced. However, for those diagnosed as noninfectious TB cases,
only a fraction of them (typically the primary TB cases) will be traced. Using average contacts
per active TB cases per year, we can derive the average number of contacts traced per year.
An important motivation for tracing primary TB cases is the fact that most such cases occur in
children. Compared with adults, children are highly susceptible to TB, and have generally acquired
the infection relatively recently. Tracing primary TB cases (which are by definition those perceived
as recent) is undertaking with the goal of identifying the source case. Tracing those infectious ones
can help stop the spread of the TB infection, and tracing the noninfectious ones can help find the
sources of the infection.
4.3.2 Parameterization
Parameters used in the model are either derived from the Saskatchewan TB Control Program
database and provided supplemental information, or from a variety of literature [20, 30, 37]. Key
parameters used in the model are depicted in Table 4.1.
Table 4.1: Description of the Symbols and Parameter Settings in TB Model with Contact
Tracing
Parameter Description Value Unit
β Likelihood of infection per contact between a suscep-
tible and an infectious active TB case
0.46 1
C Average number of contacts per TB case per unit
time (year)
40.96 persons
per year
Pr The proportion of protected people with latent TB
infection at risk for active TB
0.32 1
pit The mean time of treatment for active TB cases 0.75 year
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pin The mean time spent under TLTBI treatment for
latently infected people
0.5 year
piin Mean Time for a noninfectious TB case developing
infectiousness
1.29 years
pidn The mean time to trace and investigate a given con-
tact of that case (averaging over all contacts)
0.25 year
µtb Mortality rate from TB 0.037 per year
µn Mortality rate from other disease 0.0274 per year
d Rate of Reactivation (Progression from latent TB to
active TB due to endogenous changes)
3.125×
10−3
per year
ρ Proportion of newly infected individuals progressing
to primary TB
0.05 1
τ Fraction of infected TB cases eligible for TLTBI 0.3 1
Ctn Average contacts per traced noninfectious TB cases
per year
13.44 persons
Cti Average contacts per traced infectious TB case per
year
54.625 persons
p Chance of an noninfectious TB case (particularly pri-
mary TB case) been traced
0.18 1
4.3.3 Calibration of System Dynamics Model
Although the model includes many parameters values estimated from the relevant datasets and
literature, there are still some parameters which can’t be retrieved or easily estimated. Most
notably, there are a large number of people with unknown/non-investigated TB status in our
model. Several studies provided us with some rough estimates of the real world situation, such as
data from mass screening for TB in Saskatchewan during the 1970s and earlier. But it is only a
rough estimation, and it is likely to exhibit pronounced variation.
In order to improve the validity and reliability of our model, it is highly valuable to calibrate
our model to best match historically observed values between 2001 and 2007. These historical data
across the time series include incidence rate, number of traced people with Mantoux positive results,
and the population size of community 1. Calibration was performed using a Powell Optimization
algorithm (used within Vensim software) [48] to adjust several parameter values so as to find the
best observed match to the historic data. The parameters to be calibrated in our model are the
birth rate, initial fraction of TB infection, initial undiagnosed noninfectious TB cases and initial
undiagnosed infectious TB cases. Firstly, birth rate was calibrated via setting its initial value as
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well as its upper and lower boundaries. Then, with use of the calibrated birth rate, the remainder
of the three parameters are calibrated by matching incidence rate and traced people with Mantoux
positivity status. Each calibration is simulated for around 100,000 times to optimize a weighted
sum of square about the discrepancies between the historical data and simulated results. The best
calibrated parameter values we can get are shown in Table 4.2.
Table 4.2: Calibrated and Estimated Symbols and Parameters
Parameter Description Value Unit
a Annual birth rate of community 1 0.0469 per year
λ Initial Fractional Prevalence of TB Infection.
Infected people with no current disease people
over the total susceptible and infected people
in community 1 at 2001
0.286 1
tdn Mean Time until diagnosis for non-infectious
active TB
0.6413 year
tdi Mean Time until diagnosis for infectious active
TB
0.5 year
Initial In Initial value of undiagnosed and Infectious Ac-
tive TB stock
1 person
Initial Un Initial value of undiagnosed and noninfectious
Active TB stock
1 person
4.4 Scenario Definitions
The main focus of our model is to investigate the effect of contact tracing on capturing the source
of infection as early as possible and in controlling the spread of the disease. In order to assist
the process of policy formulation and decision making in disease control using the model, we have
designed a variety of scenarios to answer two what-if questions, and each scenario is simulated from
2001 to 2030 to investigate the potential outcomes under different parameter settings.
• Question 1: How would the benefits of contact tracing vary if contact tracing were to be carried
out on various fraction of the contacts of infectious active TB cases (e.g. 10%, 20%, 50% or
all contacts)? To assess the cost-effectiveness of tracing all contacts, compared to tracing only
a subset such as those thought to be at high risk (e.g. by reasons of prolonged or intimate
exposure), we frame the question in the context of a community whose identity is restricted
for reasons of confidentiality (community 1) by asking what level of incidence of active TB
would result from tracing an successively larger fractions of contacts of an infectious active
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TB. We firstly abstract away from the issue of differing levels of risk for different subsets of
the contact population, and instead consider the impact of investigating different fractions of
the contact population, assuming an equal distribution of risk across that population. What
might the incidence rate be if contact tracing is not performed? How much improvement in
disease control can be attributed to a contact tracing investigation? In addition, considering
the risk in terms of the incidence rate of active TB, we also explore the impact of partial
contact tracing on prevalence of TB infection across the overall population.
• Question 2: If we improve the speed of contact tracing, what would the impact be on TB
incidence rate and prevalence over the time? Tracing contacts more promptly provides an
opportunity to reduce exposure time and new TB infection cases. If we go a step further,
lowering the number of newly infected people can eventually reduce the prevalence of TB
infection as well as the incidence rate of active TB. Considering the highest level of popula-
tion health, it is natural to seek to operate contact tracing investigation as fast as we can,
nevertheless we are bounded by a limitation of human resources and budgets. A step towards
understanding the cost-benefit trade-off of contact tracing speed is to evaluate the benefits of
speedier contact tracing. If public health authorities can deploy sufficient resources to reduce
the mean time of contact tracing by a factor of 10 or even of 20, what attributable level of
benefit would be secured? How many new TB infection cases can be eliminated? Our TB
model seeks to explore these potential gains in the context of TB transmission.
4.4.1 Sensitivity Analysis on Coefficient of Tracing Contacts
This experiment is designed to answer question 1 about the impact of tracing partial contacts
of active TB cases. As a first step, we set our calibrated baseline model to represent ongoing
contact tracing. For the calibrated baseline model, the coefficient of investigated contacts is 1
(or 100%). Then based on this calibrated baseline model, we adjusted the coefficient of contacts
coming into investigation to 0%, 10%, 50% and 150% of that baseline value. Coefficient with value
of 0% indicates that there are no contact tracing ongoing within community 1, while 150% means
we spend extra effort in the interview session to identify additional contacts, with an additional
50% margin of those reported contacts coming into investigation. This analysis is based on the
assumption that people might not report their full social networks and contacts due to difficulties
in recollection or personal reasons, and the response rate can hardly be 100%, since contacts might
have problems coming into investigation due to personal mobility or other reasons.
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Figure 4.2: Prevalence of Active TB Corresponded with Different Coefficients of Investi-
gated Contacts
4.4.2 Sensitivity Analysis on Mean Time of Contact Tracing
Within this scenario, we sought to investigate the effect of accelerating or decelerating the contact
tracing process on TB control as a whole. For this experiment, we conducted simulations with
different mean time for contact tracing including both speeding up and slowing down by a factor
of 10 or even of 20. For this experiment, the coefficient of investigated contacts remained 1 for all
experiments.
4.5 Experimental Results
4.5.1 Results of Coefficient of Tracing Contacts
Figure 4.2 presents the results for scenarios examining changes to the assumptions regarding the
breadth of contact tracing. Absent contact tracing, the model suggests that the prevalence of active
TB will be increasing over time, and it reaches 1.54% in 2030. However, for scenarios with contact
tracing, the prevalence of active TB declines over time, following a peak at roughly 2003. Tracing
contacts at 10% of the baseline level shifts the increasing trend of prevalence into a decreasing one
after a short period of increasing between 2001 and 2003. When tracing 50% of the baseline level,
the prevalence of active TB decreases dramatically. When tracing at 100% of the baseline level,
although the prevalence of active TB (0.53% in 2030) is lower than that resulting from tracing at
50% of that level (0.67% in 2030), the incremental benefits are very limited. In short, the reduction
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Figure 4.3: Active TB Incidence Rate for Different Coefficients of Investigated Contacts
in prevalence secured by tracing the first 50% of the baseline level of contact tracing(0.87%) is much
larger than that obtained by tracing at 50% of the baseline level (0.14%).
Figure 4.3 shows the impact of additional levels of contact tracing on the incidence rate for
Active TB. All scenarios initiate with a transient consisting of a sharp rise in the incidence rate.
This transient suggests an inconsistency between factors within the model, such as between of the
fraction of infection assumed within the initial population on the one hand, and the rates of mixing
(c) and transmissibility of the bacterium within this epidemiological context (β). Absent contact
tracing, the active TB incidence rate increases slowly following the initial transient. When tracing
at 10% of the baseline level, the incidence rate lies below that resulting from no contact tracing with
a declining trend. When tracing at 50% of the baseline level, the incidence rate declines slowly over
time after reaching its peak around in 2003. The incidence rate decreases faster after 2002 when
tracing more contacts, but once again the extra benefits we obtain when tracing incrementally larger
fractions of contacts (compared to the baseline) yield markedly decreasing returns. For example,
tracing an extra 50% increase in the rate relative to the baseline scenario contributes even smaller
benefit.
4.5.2 Results of Mean Time of Tracing
This experiment tries to answer question 2 regarding the impact of reducing the mean time of
contact tracing on TB control, as judged by the prevalence of active TB. According the trend lines
displayed in Figure 4.4, as a whole all the trajectories have the declining tendency over the time,
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Figure 4.4: Prevalence of Active TB Produced by Different Mean Time of Tracing Contacts
Figure 4.5: Fraction of Actively Diagnosed Cases Among All Incident Cases
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except for the initial transient. We observe that changing the mean time of contact tracing slightly
around the baseline doesn’t provide pronounced benefits in TB control. The impact of decreasing
the mean time of contact tracing even by integral factors (e.g. a factor of 2 or 3) is very small,
and for small changes, the impact can almost be ignored. Even for larger changes (such as the
factors of 10 times shown in the diagram), the impacts are very limited (e.g. prevalence of active
TB in 2010: 20x slower=0.98%, 10x slower=0.92%, baseline=0.84%, 10x faster=0.84% and 20x
faster=0.84%). While the aggregate character of the model suggests the need for great caution,
such results suggest that there may be limited gains to be secured by investments in reducing the
time required for contact tracing.
Figure 4.5 illustrates the fraction of actively diagnosed cases among all the incident cases over
time. As a whole, all the trajectories increase first and decrease afterward. The year in which
the fraction of actively diagnosed cases reaches its peak for each scenario is presented as: 20x
slower=2011, 10x slower=2008, baseline=2003.5, 10x faster=2003.2 and 20x faster=2003.2. We
observe that the faster contact tracing investigation goes, the sooner the fraction of the actively
diagnosed cases reach its peak.
4.6 Discussion and Conclusion
The first question explored in this paper concerned the impact of tracing partial contacts on disease
control and prevention. In this area, our models have explored a few alternatives focused on tracing
subsets of the contacts. Model results suggest that the impact of contact tracing is pronounced in
TB control as we have observed dramatic decrease in incidence rate and the prevalence of active
TB. For the scenarios exploring partial tracing, we found that incidence rate decreases when tracing
successively larger fractions of contacts; however, the contribution of tracing more contacts declines
markedly. This phenomenon of diminishing returns would appear of relevance when developing
control policies. The results suggest that strong gains can be obtained when tracing merely partial
contacts. Given limited resources, it also tentatively suggests that tracing partial contacts may
be more effective and beneficial especially when we set priority for contact tracing to those with
high risk (such as those experiencing longer exposure times, or individuals who are known to have
experienced past contacts with several other cases).
Our second investigation sought to understand the mean time of contact tracing. Within this
area, the model was used to explored a few scenarios. Given model assumptions, TB control
effectiveness is relatively insensitive to mean time of contact tracing especially within the large
range of 20 times faster to 20 times slower than the baseline. When reducing the mean time of
contact tracing and boosting the effort to track TB cases sooner compared to the baseline, the
achievement yields only modest gains and the patterns are similar to that obtained at baseline.
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This suggests that there may be unexpected degrees of flexibility in the speed of tracking contacts,
and raises the interesting possibility that the current guidelines and schedule for contact tracing
are sufficient fast to secure most of the benefits to be gained through contact tracing.
By contrast, through experiments with different fractions of contacts coming into investigation,
it is found that assumptions regarding the fraction of contacts coming into investigation yield
pronounced impacts for the prevalence of TB infection. Bringing larger fractions of contacts of
individuals in for contact tracing can yield a reduced prevalence of TB infection. Tentative though
they are, the results suggest that the gains exhibit diminishing returns. Depending on the relative
cost of undertaking contact tracing and the cost of treating TB, putting into place some basic
measure of contact tracing would appear likely to yield the greatest incremental benefit (when
compared with enhancing the level of tracing experienced in a program already drawing many
contacts).
While deducing the optimal level of contact tracing will require consideration of the cost trade-
offs involved. Such diminishing returns suggest that there is likely to be decreasing cost-effectiveness
for bringing in larger sets of individuals. While the current model did not seek to capture important
known risk factors for TB, such observations would suggest that focusing limited contract tracing
effort on a smaller segment of all contacts who have a very high risk of being infected or of developing
active TB given infection could yield disproportionate benefit. Such high-risk individuals would
include contacts who are known to have had contacts with many other cases, and those in the top
risk categories currently used by TB control. With priority setting in tracking the contacts, the
striking gains from partial contact tracing seen here will likely be significantly more efficient yet.
We were surprised to find such limited incremental effectiveness due to reductions in the time
required for performing contact tracing. In Figure 4.4, we did not observe significant improvements
in prevalence of active TB while implementing a faster contact tracing protocol. This phenomenon
merits close additional study before any definitive policy-relevant implications are drawn, it raises
the provocative possibility that the current speed of contact tracing may be securing the large
majority of the benefits that would be gained even by far faster contact tracing. It is undeniable
that speeding up the contact tracing process would offer some benefits, but in the context of
limited health resources (funds and working staff), model results raise the distinct possibility that
the benefits from such speed-ups may be less than the associated opportunity cost.
At a more fundamental level, model experimentation with the scenario results suggests that,
when viewing the situation from a cost-effectiveness standpoint, it is important to recognize that
contact tracing is, in a sense, “self-limiting”. This effect is particularly notable with respect to
the speed of contract tracing. Initially, rapid contact tracing will quickly reduce the incidence -
and, more slowly, the prevalence - of active TB. The more rapid is the contact tracing involved,
the sooner will these rates fall. However, whether these gains are achieved sooner or later, the
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results tend to converge. This convergence reflects the fact that reduced active TB prevalence in
the population limits the efficiency of contact tracing by imposing larger numbers of contacts to be
traced before a case of infectious TB can be located. It is entirely possible that finding an active TB
cases needs to test hundreds of contacts and require many resources and much money. As a result,
regardless of how quickly the prevalence of active TB initially decreases, these initial decreases will
slow significantly due to the inefficiency of contact tracing, and will converge to similar levels of
prevalence (an effect seen clearly in Figure 4.4 and Figure 4.5).
At this point, the greatest gains in efficiency may be secured by effective risk prioritization,
which could allow the given investment in resources to secure significant additional benefit [4]. By
contrast, while its dependence on passive methods of diagnosis (in which an infective individual
presents for care, typically as a result of symptoms) can allow significant reservoirs of infective
cases to circulate in the population, the efficiency of passive diagnosis is less adversely affected by
decreasing prevalence of TB than is contact tracing with an important exception being the reduced
likelihood that a given physician will recognize TB within a population in which TB circulates at
low levels. In this sense, contact tracing can easily become a “victim of its own success”, with
its initial successful reduction of the prevalence of TB tending to reduce over time the fraction of
all active TB cases that are brought in via active diagnosis, and over time shift larger burden of
case-finding to passive methods. It is important to emphasize that a situation in which low fraction
of case-finding occurs due to active methods of diagnosis, should not automatically be taken as
an indictment of the limited efficiency of contact tracing per se. It may well be the case that the
presence of contact tracing processed is what has allowed for the lowering of prevalence to the
current point, and the maintenance of the system at low levels of active TB. In so doing, it is likely
that it will make itself appear “inefficient” to the amount of effort entailed in finding new infectious
cases - but this apparent “inefficiency” belies the key role of contact tracing in achieving the current
situation.
While the preliminary and aggregate character of the model suggest the need for great caution
in interpreting model results in a quantitative fashion, the simulation outcomes suggest some very
tentative public health related implications in disease control and policy formulation. This study
has focused on contact tracing investigation within the context of an aggregate simulation model.
While simulation of contact tracing can very naturally be carried out at an individual level, System
Dynamics modeling can assist in the process of policy optimization by running different scenarios
to predict potential control outcomes. Modeling within this area raises the potential for maintain-
ing more judiciously chosen programs and enhancing the reliability and validity of deploying new
prevention strategies.
However, the model described in this paper exhibits significant drawbacks. Firstly, our imple-
mentation of contact tracing ignores the underlying contact patterns within the population. Due
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to the nature of the aggregate model, it cannot readily be used to investigate existing or prospec-
tive alternative contact tracing protocols, because it deals with people in an aggregate way rather
than as individuals. In addition, the model does not capture the population heterogeneity in risk
across the population. Among other factors, the assumption of a homogeneous population limits
our capacity to investigate targeted contact tracing strategies, which could be highly important for
enhancing the efficiency of contact tracing. We are currently working to address this shortcoming
using simulations on individual-based model with network structure. An individual-based model
would provide a natural vehicle for examining the impact of expediting contact tracing according
to the levels of risk factors. A further limitation of the current model is the failure to represent
BCG. Although we recognize the potential importance of protection conferred by BCG, we have
not represented its impact on preventing TB infection in our model for several reasons. The first of
these reasons is limited data: many individuals in the TB database employed lack BCG informa-
tion recorded in their files. In addition, the BCG data that is available is imprecise: most traced
individuals have limited recollection as to whether or not they underwent inoculation with BCG.
Finally, recognizing the considerable variability in the epidemiological data on BCG efficacy [51],
the degree of efficacy of the BCG vaccine is unclear and controversial.
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Chapter 5
Estimating the Effectiveness of Contact Trac-
ing on Tuberculosis Outcomes in Saskatchewan
Using Agent-based Modeling
Chapter 4 introduced a System Dynamics model to evaluate the effectiveness of contact tracing
in TB control at the aggregate level. However, due to the limitations of aggregate models, the
impacts of population heterogeneity and network structure haven’t been explicitly examined in
that aggregate model. In this chapter, we employ another aggregate System Dynamics TB model
[37], and transfer it into a stochastic agent-based TB model with contact tracing strategies to
further investigate prospective contact tracing protocols.
5.1 Scheme of the System Dynamics Model of TB Trans-
mission in Saskatchewan
Before proceeding, the prototype of aggregate TB model which we employ in our agent-based
TB model is introduced. The System Dynamics TB model in [37] is a well calibrated aggregate
TB model with implementation of 2 important risk factors (namely age and ethnicity) and TB
preventions for the population in Saskatchewan (e.g. BCG and TLTBI). Figure 5.1 demonstrates
the aggregate model structure. Here rectangles denote states in which a person could possibly stay,
and solid arrows denote transitions via which a person can update their states. The dotted arrows
which are directed into the state are either birth or immigration; a new person (either an immigrant
or a new-born) can enter the associated states via such pathways. In addition, those dotted ones
directed out of the state denote death either from active TB or reasons other than TB. There are
11 stocks used to characterize the TB related status; each of those stocks is additionally further
stratified by age group and ethnicity. In this model, age group and ethnicity constitute risk factors;
people in the younger age group experience a higher risk of TB infection given exposure, and First
Nations people also hold a relatively higher chance of TB infection and progression. Moreover,
age and ethnicity are also considered when representing the TB transmission; the force of infection
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is formulated by constructing contact matrices to capture mixing patterns – such as the fact that
people (all other things being equal) will tend to have greater levels of contact with others of similar
ethnicity or age.
According to Figure 5.1, uninfected individuals can either go to the “BCG vaccinated” stock via
vaccine or to the “high-risk latent” stock via acquiring a new TB infection [37]. People who remains
in the “BCG vaccinated” stock still can acquire TB infection but with a lower chance compared
to those without vaccine. Those who are present in the “high-risk latent” state can develop active
TB via primary progression, receive treatment for latent TB infection (TLTBI), or transition to
the “low-risk latent” stock. Individuals in the “low-risk latent” stock can return to the “high-risk
latent” stock when they are re-infected. Persons who are protected by TLTBI can either progress to
active TB or return to the “low-risk latent” stock after the waning of protection. States associated
with Active TB are stratified by infectiousness, diagnosis and treatment. In addition, people who
were previously treated for active TB but lack current disease will remain in the “latently infected
with previous treatment” stock.
Figure 5.1: Model Structure of System Dynamics TB model in [37]
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5.2 Agent-based TB Model Regarding Contact Tracing
We employ the model structure illustrated in Figure 5.1 and TB related parameters for TB trans-
mission components in our agent-based model to characterize TB transmission in Saskatchewan.
Contact tracing procedures and statistical data are gathered from the Saskatchewan TB Control
Program and supplemental datasets. AnyLogic 6.2.2 Software is used to construct the stochastic
agent-based model and conduct simulations. The UML diagram of the overall model structure is
depicted in Figure 5.2. The Person class is defined with sophisticated behaviors and numerous
characteristics with respect to TB transmission, diagnosis and treatment, aging, contact tracing
investigation, and personal status (such as ethnicity, sex, etc.). The MYSQLDB class is created
to store the model results and meta-data associated with different scenarios, and the Main class is
the root of the simulation which stores all the parameters and statistics of results. The detailed
implementation of each component will be illustrated in the following sections.
Figure 5.2: Hierarchy of the Overall Model Structure in UML Diagram
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5.2.1 Network Structure
The network structure in the context of the TB transmission model is composed of nodes and
edges, which represent independent individuals (with different TB related status) and their links
with other individuals, respectively. We can consider this network as an undirected graph. The
number of edges not only defines the degree of an individual, but also depicts the interactions
among the individuals as well as the transmission pathways through which the TB infection can
spread. For example, a link between 2 individuals indicates that TB can be transmitted via this
connection if one of them is an undiagnosed infectious active TB case.
The underlying contact structure plays a crucial role in infectious disease spread; however, with
limited knowledge of the actual network architecture, it is difficult to determine and explore the
exact network structures and human behaviors in many cases. Given the advantages of agent-based
modeling, we can easily investigate the consequences of assumptions about the underlying network
structure of the population, and represent the individuals within a network environment. Such
representation provides the opportunity to explore the questions regarding how TB transmission
and its control strategies are affected by the underlying social network structure.
We investigate the impact of assuming that the underlying contact network adheres to a random,
scale-free and small world network structure. By simulating contact tracing on such an underlying
network, we can obtain a contact tracing network over the exact contact network; estimating such
networks might help understand the difference between the hypothetical contact network (for which
we don’t have knowledge) and the contact tracing network (about which we collect information
during the contact tracing process).
In many studies, the network models for disease spread assume a closed population – that is,
they assume a fixed number N of nodes without modifying the N. In contrast, the social networks
in the real world represent open systems and are subject to dynamics in the form of removal and
insertion of nodes and edges. In our model, the contact network is a dynamic one where the
population is open and changed by birth and death over time. Although it would obviously be
more realistic to have breaking and forming of relationship due to reasons other than birth or
death, without information collected at such detailed level, we decided to keep the links amongst
individuals static for the duration of the simulation, with the exception of those edges changing
because of births and deaths. The characteristics of different network architectures are maintained
in such an open population over time by keeping the average connections per individual stable for
all of the simulated network topologies, and by employing preferential attachment based on the
node’s degree for the scale-free network.
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Figure 5.3: TB Transmission Statechart in Agent-based Model
5.2.2 TB Transmission Statechart
Each individual in the network environment has 3 statecharts which represent TB status, aging
and contact tracing. Figure 5.3 shows the TB status statechart. Similar with the stocks in the
System Dynamics TB model, there are 11 state in the TB status statechart: “Uninfected” (U);
“BCG Vaccinated” (V ); “High Risk Latently Infected” (Eh); “Latently Infected Protected Via
TLTBI” (Ptltbi); “Low Risk Latently Infected” (El); “Active UnDx Noninfectious TB” (TBuninf ),
i.e. individuals who are currently diagnosed; “Active UnDx Infectious TB” (TBinf ), i.e. individuals
with infectious active TB who can transmit infection, but who are currently undiagnosed; “Active
TB Under Treatment” (R); “Latently Infected With Previous Treatment” (Eex); “Active UnDx
Noninfectious TB With Previous Treatment” (TBex,uninf ); “Active UnDx Infectious TB With
Previous Treatment” (TBex,inf ). The transitions between states are illustrated in Figure 5.3, and
the details of the transitions are presented below.
• Vaccination U(Uninfected) → V (BCG Vaccinated). BCG is a vaccine against TB. The BCG
rate per year (stratified by ethnicity) in this agent-based model is derived from the historical
BCG vaccination count data in Saskatchewan and the aggregate TB transmission model [37].
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• Infection U(Uninfected) → Eh(HighRiskLatentlyInfected). In our model, the chance of ac-
quiring TB infection depends on a contact process (operationalized via infection message
receiving) with neighboring nodes (infectious nodes in particular) in the network, and the
probability of having been infected (β) given such exposure. The term βc (the same one used
in [37]), stratified by ethnicity, is used when calculating the force of infection (e.g. βc for
registered Indian is 38.0299, βc for non-registered Indian is 28.9106), these values are derived
from calibration with historical data in Saskatchewan. In addition, the relative risk (RR) of
TB infection for different age categories and ethnicity is also introduced to capture individual
heterogeneity in terms of TB infection (e.g. RR of TB infection for age between 0 and 4 is
11.1094, RR of TB infection for age between 5 to 9 is 14.7316, and it equals to 1 for the rest
age groups), these values are obtained via calibration.
• Infection V (BCG Vaccinated) → Eh(High Risk Latently Infected). This transition is anal-
ogous to the transition U → Eh, and it is a network-dependent process. The difference
between this transition and the infection transition U → Eh extends from the relative risk
of acquiring TB infection. Given TB exposure, the relative risk of been infected is lower for
vaccinated individuals (especially children) compared with those without vaccine, BCG vacci-
nation significantly decreases the risk of TB by 50% on average, and vaccination of newborns
and infants reduces the risk even more [7, 8]. In our model, the RR of TB infection given
BCG is implemented as 1 for each age group. Compared with the RR of TB infection absence
of BCG, it is lower for the children under 9 years old, but is maintained the same for the
individual above age 9.
• Eh(High Risk Latently Infected) → El(Low Risk Latently Infected). The model divides
latently infected persons into 2 categories (a high risk group versus low risk group) regarding
different level of risk with respect to developing active TB. Such classification of latently
infected individuals gives a better representation of TB progression than does assuming a
uniform risk of progression to active TB among all latently infected individuals. According
to the facts regarding TB [43, 45, 54], around 10% of infected people will develop Active
TB in their lives; approximately 5% of them will develop Active TB in the first 2 years
after acquiring TB infection; the remaining 5% will develop Active TB later in their lives.
This transition applies a mean time of 2 year delay to distinguish different levels of risk of
developing Active TB.
• Primary Progression Eh(High Risk Latently Infected)→ TBuninf (Active UnDx Noninfectious
TB). This is a network-independent transition, and the natural process of primary progression
is captured via active TB progression after a shorter latency period in state Eh (less than 2
years since infection).
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• Re-infection El(Low Risk Latently Infected)→ Eh(High Risk Latently Infected), Eex(Latently
Infected With Previous Treatment)→ TBex,uninf (Active UnDx NonInfectious TB With Pre-
vious Treatment). A small fraction of the individuals in state El and Eex are represented as
having been re-infected (e.g. reinfected by another string of mycobacteria), and this transi-
tion is dependent on network and on the probability acquiring infection upon contact with an
infectious TB case. The proportion of latently infected individuals susceptible to exogenous
re-infection is 25% in our model [20].
• Treatment for Latent TB Eh(High Risk Latently Infected) → Ptltbi(Latently Infected Pro-
tected Via TLTBI). This is a contact tracing related transition. Investigation of contacts of
the traced active TB case will trigger treatment for latent TB infection via message sending
and receiving. Contacts who are found in the state Eh with age less than 35 are treated as
being eligible for this treatment.
• Ptltbi(Latently Infected Protected Via TLTBI) → El(Low Risk Latently Infected). This
transition represents the delay between state Ptltbi and the state El. It is estimated that the
mean time of protection given by treatment for latent TB (TLTBI) is 7 years [37].
• Ptltbi(Latently Infected Protected Via TLTBI) → TBuninf (Active UnDx Noninfectious TB).
The proportion of protected population with TLTBI at risk of developping active TB is
derived as 32% [37].
• Natural Recovery TBuninf (Active UnDx Noninfectious TB) → El(Low Risk Latently In-
fected), TBex,uninf (Active UnDx Noninfectious TB With Previous Treatment)→ Eex(Latently
Infected With Previous Treatment). These transitions represent natural recovery from active
TB, and the calibrated rate of natural recovery from active TB is 0.1 per person per year for
registered Indian, and 0.1638 per person per year for non-registered Indian.
• Reactivation El(Low Risk Latently Infected) → TBuninf (Active UnDx Non Infectious TB).
Low risk infected individuals can reactivate and progress to active TB (known as endogenous
reactivation) via this transition.
• Progressing to Infectious State TBuninf (Active UnDx Noninfectious TB) → TBinf (Active
UnDx Infectious TB), TBex,uninf (Active UnDx Noninfectious TB With Previous Treatment)
→ TBex,inf (Active UnDx Infectious TB With Previous Treatment). Individuals in TBuninf
or TBex,uninf can become infectious TB with a mean delay time of 1.29 years.
• Passive Diagnosis of Noninfectious Cases TBuninf (Active UnDx Noninfectious TB)→ R(Active
TB Under Treatment), TBex,uninf (Active UnDx Noninfectious TB With Previous Treatment)
→ R(Active TB Under Treatment). The passive diagnosis process is represented with a delay
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with a mean time of 2.9 years for noninfectious case without previous TB, while the mean
time of diagnosis for those with previous TB is adjusted by a coefficient of 0.5.
• Active Diagnosis of Noninfectious Cases TBuninf (Active UnDx Noninfectious TB)→ R(Active
TB Under Treatment), TBex,uninf (Active UnDx Noninfectious TB With Previous Treatment)
→ R(Active TB Under Treatment). These transitions are triggered by contact tracing proce-
dures via message interactions within the contact network. Contact tracing can help identify
undiagnosed active cases. As represented, contacts who are found with active TB by contact
tracing are diagnosed actively. Contact tracing might follow on the diagnosis procedure to
further investigate potential infected contacts or identify the source of infection; however,
the follow-on activity depends on protocol and underlying objective of the contact tracing
investigation.
• Passive Diagnosis of Infectious Cases TBinf (Active UnDx Infectious TB) → R(ActiveTB
Under Treatment), TBex,inf (Active UnDx Noninfectious TB With Previous Treatment) →
R(Active TB Under Treatment). Similar to the diagnosis process of noninfectious active TB
cases, a delay is used to represent these 2 diagnosis transitions. Compared with the mean
time of diagnosis of noninfectious TB cases, the mean time of diagnosis of infectious TB cases
without previous TB, which is treated as 0.1 year for non-First Nations people and 0.22 year
among First Nations individuals, is much shorter due to the fact that individuals at this
stage are more likely to have obvious symptoms and seek health care examination. In the
default contact tracing protocol, these transitions also trigger the contact tracing to further
investigate the next generation of infected individuals.
• Active Diagnosis of Infectious Cases TBinf (Active UnDx Infectious TB) → R(Active TB
Under Treatment), TBex,inf (Active UnDx Noninfectious TB With Previous Treatment) →
R(Active TB Under Treatment). The occurrence of these transitions are activated by contact
tracing, and they are network-dependent. Depicting the diagnosis of infectious cases by
contact tracing, these 2 transitions are not only the result of contact tracing, but also another
starting point of contact tracing investigation.
• Treatment R(Active TB Under Treatment) → Eex(Latently Infected With Previous Treat-
ment). There are 2 transitions which remove nodes from state R to state Eex, and they are
triggered by the rate of annual likelihood of treatment completion and the rate of treatment
default occurring with latent TB (taking into account the fact that some of the relapsed
individuals still have non-infectious active TB).
• Relapse Eex(Latently Infected With Previous Treatment)→ TBex,uninf (Active UnDx Nonin-
fectious TB With Previous Treatment), R(ActiveTB Under Treatment)→ TBex,uninf (Active
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UnDx Noninfectious TB With Previous Treatment). Removal of a person from state R to
TBex,uninf refers to the relapse happening among the persons in state R. Prior to the Di-
rectly Observed Treatment (DOTS), there was a high relapse rate among the active TB cases
due to failure of treatment or low compliance. Individuals within state Eex can also relapse
to active TB.
• Birth and Death. Birth and death can change the network structure by forming or breaking
the connections of the nodes. The birth and death rate in our model are applied the same as
those in [37] which are derived from historical Saskatchewan birth count data and historical
death rate.
Most of the rates used in the transitions above vary according to different age group or ethnicity
to provide more accurate measure of the TB progression and its interaction with risk factors.
5.2.3 Contact Tracing Statechart
Given the advantages of individual-based modeling techniques, we can implement contact tracing
at an individual level with more detailed representation of the contact tracing procedure in the
real world, which we hope will eventually provide a more robust and accurate estimation of the
effectiveness of contact tracing.
Contact Tracing Procedure
Starting from an infectious TB case, diagnosed either actively through previous contact tracing or
passively due to illness and the presence of obvious symptoms, a number of potential contacts will
be identified by contact tracing investigation. Contacts whose records demonstrate that they are
associated with previously positive skin tests (also known as a “TST test” or “Mantoux test”),
usually will not be re-examined again unless they are the contacts of a primary TB case (in which
case they may be examined for the sake of reverse contact tracing), since they are known as
tuberculin reactors. The remaining contacts are typically notified via a letter that they are sought
for examination. The objective is to have 95% of the contacts examined within 30 days since the
TB case is identified [43], and to maintain a low level of loss to follow-up in both skin test and
clinical review.
Figure 5.4 depicts the flow chart with respect to contact tracing and the decision making pro-
cesses. Usually there are 3 steps for investigating a contact, namely a first skin test, a potential
second skin test, and clinical review. However, the examination procedure for a particular individ-
ual does not necessarily transition through all these 3 steps; the next step test depends highly on
the previous test outcome as well as on the personal history information. For example, a contact
doesn’t need a second skin test if we know he or she is TST positive in the first test. Treatment for
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either active TB or latent TB are assessed by the clinical review, which includes standard testing
and diagnosis procedures, such as X-ray, culture and smear test. Contacts of primary TB cases –
even those previously skin test positive – will be examined to infer the source of infection. Loss of
contacts follow-up can happen in each step of the contact investigation procedure.
According the contact surveillance information from the years 2004 to 2008 in Table 5.1, the
objective of investigating 95% of the contacts within 30 days is not well accomplished. The cross-
year average percentage of the contacts examined following the current surveillance procedure within
30 days, 90 days, 180 days and 365 days of identifying the active TB cases are 22.8%, 73%, 94.2%,
99.4%, respectively. Obviously, there is still great effort required to meet the stated scheduling
goals of contact tracing investigations.
Table 5.1: The Cumulative Percentage of Contacts Examined at Each Interval (Contact
Surveillance of Saskatchewan from 2004 to 2008, obtained from Saskatchewan TB Control)
Year/Days 30 90 180 365
2004 21 81 97 99
2005 22 71 95 99.8
2006 24 77 99 100
2007 31 78 96 100
2008 16 58 84 98
Average 22.8 73 94.2 99.4
Figure 5.5 illustrates a scenario of investigating an infectious active TB case, and the overall
information collected from Saskatchewan TB control regarding the lost of follow-up and tracing
procedure. Based on the contact tracing outcome from Saskatchewan TB Control between years
2001 to 2006, roughly 15% of the contacts were unavailable for skin testing. Among those who
were skin tested, 51.54% of contacts with negative result in their first skin test were lost follow-
up in their second skin test and a potential clinical review, while 38.92% of those with positive
results missed their clinical review for active TB disease. Such loss might significantly undermine
the effectiveness of contact tracing, and the analysis of the impact of this loss to follow-up merits
further investigation.
Contact tracing is currently limited to two categories of the clients: Those who have infectious
TB or primary TB. Suppose an infectious active TB cases is diagnosed such as that shown in Figure
5.5; the nurse will create a contact list for the case, and ask for his or her contacts in the 30 days
before the diagnosis. A contact list sorted by the amount of exposure time is recommended. The
objective of tracing infectious TB cases is to find infected people, people with active disease and
people with infectious disease. The main potential infected contacts for this case include preschool
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Figure 5.4: Contact Tracing Protocol and Tests
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children, persons who breathed the same indoor air as the case as well as contacts of the case within
30 days before diagnosis. Usually a letter of notice will be mailed to the contacts, then contacts
are scheduled to finish their skin test first, those whose skin tests are significant will be brought
into the system for further assessment for disease. There is variations in the duration between
case diagnosis and contacts investigation, and relevant descriptive statistics is shown in Table 5.1
and Figure 5.5. The diagnosis of persons with active disease by contact tracing is classified as
active diagnosis. However, the procedure for tracing primary TB is somewhat different from that
of tracing infectious cases. The target for this process – termed “Reverse contact tracing” – is to
identify the source of infection, and the focus is contacts age 15 years and older as well as contacts
during 30 days period to diagnosis. When the source is believed to be known up front, the contact
skin testing trace is not required. In addition, contact skin testing will be discontinued when the
source is found. For example, the second skin test is not necessary if the first test is not significant
because these contacts are not the source (they were evidently not infected and not suffering from
active TB at the time of the contact).
Contact Tracing Implementation
In order to capture the principles of contact tracing in conjunction with TB progression, a contact
tracing statechart is created in the Person class to represent details of the protocol of investigating
contacts. Figure 5.6 illustrates the statechart of contact tracing within our agent-based model, and
it interacts with the TB transmission statechart to simulate the investigation procedure. Here, the
diagnosis related transitions in TB transmission statechart assist in initializing a prioritized queue
of contacts for a diagnosed active TB cases (mainly primary TB and infectious TB case), then
further assessment on contacts will be conducted (such as eligibility for investigation, previously
investigated or not); afterward message of notice will be sent to the qualified contacts. Usually
only a fraction of the contacts will be named by the TB case. The priority score of each contact
is calculated based on the RR of TB infection by age, ethnicity and number of times an individual
has been reported as a contact. A Higher score refers to higher risk as well as higher ranking in
the queue list of the contacts to be interviewed.
Individuals can be in one of five states with regards to their contact tracing status which is
shown in Figure 5.6, namely “PotentialContact”, “ReceivedNotice”, “Mantoux1stSkinTest”, “Po-
tential2ndSkinTestandclinicalReview” and “PreviousPositive”. Initially, individuals are sitting in
the “PotentialContact” state. Upon receiving the contact notice messages, the contacts will go to
“ReceivedNotice” state. Then the “Mantoux1stSkinTest” state represents a situation where people
are currently waiting for their 1st skin testing. While “Potential2ndSkinTestandClinicalReview”
state represents the clinical review procedure for those positive in the 1st TST test; for those who
are negative in the first TST test, it stands for the second skin test and a potential clinical review
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Figure 5.5: Contact Tracing Investigation(CTI) Procedure and Facts
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procedure. According to the historical data, we lost 4.4% contacts between the second skin test
and clinical review. Since the lost is modest, we assume there is no lost between the second skin
test and clinical review to simplify the implementation without losing too much information. “Pre-
viousPositive” is a state for the past TB cases and those previously investigated with positive skin
test results. The implementation of the transitions in the contact tracing statechart is as follows.
Figure 5.6: Contact Tracing Statechart in Person Class
• “PotentialContact” → “PreviousPositive”. This transition is triggered when an active TB
case is diagnosed and ready for treatment. An active TB case is known as tuberculin reactor
and shows positive results in the skin test.
• “PotentialContact” → “ReceivedNotice”. This is a message and network dependent tran-
sition. When contact tracing is enabled, diagnosis of an active TB case might trigger this
transition by investigating his or her contacts. Notice messages are sent by the index case via
the contact network.
• “ReceivedNotice” → “Mantoux1stSkinTest”. This is a timeout transition. The speed of
investigating contacts in the model is based on information regarding contact surveillance
speed in 2008, shown in Table 5.1.
• “Mantoux1stSkinTest” → Branch→ “PotentialContact”. Lost follow-up after the first skin
test is captured via this transition. Negative contacts can follow this transition and go back the
“PotentialContact” state, since they are uninfected and fully eligible for future investigation.
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• “Mantoux1stSkinTest” → Branch → “PreviousPositive”. This transition represents loss of
contacts with positive results in their first TST test, and they are known as previous positive
even just finishing the first skin test. We assume that these individuals can be investigated
again only if they are nominated as a contact of a primary case for reversing contact tracing.
• “Mantoux1stSkinTest” → “Potential2ndSkinTestandClinicalReview”. A delay between the
first skin test and clinical review is represented in this transition.
• “Potential2ndSkinTestandClinicalReview” → Branch → “PotentialContact”. If a contact
shows negative results again in the second TST test, then the investigation is done and he
can go back to “PotentialContact” state.
• “Potential2ndSkinTestandClinicalReview”→ Branch→ “PreviousPositive”. If an individual
shows significant result in the potential second skin test or the clinical review, then he or she
will go to “PreviousPositive” state afterward. Treatment for Latent TB infection and active
diagnosis of new TB cases are assessed in this transition as well.
• “PreviousPositive” → “Potential2ndSkinTestandClinicalReview”. This transition is used in
reverse contact tracing only. Those who are previously skin test positive will be reviewed
again to assess the source of infection of a primary TB case. This is a message dependent
transition with chance of losing follow-up in the clinical review.
5.2.4 Parameterization
The TB model is calibrated to fit the TB epidemic in Canadian province of Saskatchewan. Key TB
related parameters applied in our model are summarized in Table 5.2. TB transmission parame-
terization was based on updated estimates from calibration of the model reported in [37], while the
contact tracing central parameters are from Saskatchewan TB Control (as presented in Table 5.1,
Figure 5.5).
Since age and ethnicity can contribute to the risk of TB infection and progression, the relative
risk (RR) of infection and primary progression are also calibrated and introduced. For example,
children and First Nations people possess higher risk in TB infection. In addition, the guidelines
for contact tracing in Saskatchewan also suggest that children under age 5 are assumed as infected
contacts if they are exposed, although they might look and feel well. The parameters estimated
via calibration assist in reproducing the historical behavior patterns which eventually enhance the
confidence regarding model reliability.
The Relative risk (in terms of the number of times an individual has been reported as a TB
contact) doesn’t affect the TB diffusion directly, instead it is applied when assessing the priority of
contacts in the investigation process, which plays an indirect role in shifting the behaviors of the
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Table 5.2: Major Model Parameters and Estimates
Value
Parameters Registered Indian Non Registered Indian
βc (Average number of infections an infectious
person causes within the course of their illness
in a fully susceptible population absent inter-
vention)
38.0299 28.9106
Relapse to active TB rate 0.0062 0.001
Natural Recovery Rate 0.1 0.1638
Mean Time Until Discovery of Undiagnosed
Infectious TB
0.2221 0.1
Primary Progression Rate 0.0142 0.0109
Mean Time Until developing infectious TB 1.29
Mean Time Until Discovery of Undiagnosed
noninfectious TB
2.9012
Reactivation Rate 0.001562
Previously Treated Death Rate Coefficient 5
Average Connections per Person in the Net-
work
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system. The most important RR values implemented in our model are depicted in Table 5.3. The
first 5 are taken from an updated (but not yet published) calibration of the model reported in [37],
and the balance are calculated from literature [3].
Table 5.3: Major RR Parameters and Estimates in Our Model
Relative Risk (RR) Values
RR of TB Infection for age 0 to 4 11.1094
RR of TB Infection for age 5 to 9 14.7316
RR of primary progression for age 0 to 4 2.3495
RR of primary progression for age 5 to 9 1
RR of primary progression for age 10 to 14 1.0444
RR of TB Infection while being reported as a contact 2 times 2.1481
RR of TB Infection while being reported as a contact 3 times 2.7396
RR of TB Infection while being reported as a contact 4 or more times 3.9381
5.3 Experiment Design
Dynamic models are designed to understand the emergent system behavior associated with counter-
factual scenarios. Our individual-based TB transmission model with contact tracing serves as a tool
to simulate the impact of different control scenarios and their potential impact on disease prevention,
especially among Aboriginal peoples. Each scenario is dependent on a set of assumptions with
respect to different network characteristics, contact investigation target populations, and prioritized
tracing protocols. Our scenarios are primarily seek to address two questions.
• 1. Given the current situation with high loss to follow-up in the contact tracing program, if
we delivered an intervention capable of reducing the loss to follow-up to some ideal level, what
would be the impact on TB incidences rate and prevalence of TB infection over time? Upon
the current data collected from contact tracing investigation, there are roughly 30% to 40%
lost follow-follow-up in the skin test and clinic review. Such loss directly reduces efficiency
in delivering treatment for latent TB infection for high risk latently infected people, as well
as in identifying active diagnosis of TB cases. Given the current situation, it is beneficial to
understand how much we have lost and how much we can improve by applying additional
guidelines to reduce such loss.
• 2. Given a situation without explicit prioritization of contact tracing, what would happen to
TB incidence rate and TB infection prevalence if we were to devote enough effort to perform
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prioritized contact tracing that places an elevated priority on high risk people? Since risk
factors of TB infection given exposure, such as age and ethnicity, have been well studied
and validated, it is interesting to explore the opportunities brought in by distinguishing and
investigating individuals according to their risk of acquiring TB infection. In addition, some
studies, which applied social network analysis on contact tracing network [3], suggest that
the number of times a contact has been reported in the contact investigation program is
another important indicator of likelihood of TB infection; and taking such a consideration
into account when deciding a contact’s priority in the process of investigation might yield
a favourable disease control outcome. Within our model’s context, we’d like to examine
the assumption of investigating contacts prioritized by number of times a contact has been
reported.
5.3.1 Population Size Selection
To address the questions above, we simulate the system describing a stylized Aboriginal community
in the Canadian province of Saskatchewan that is treated as having an initial population size of
roughly 15,000 individuals (90% Registered Indian) for a period of 20 years.
Because we are assuming a stylized population – rather than mimicking a particular region –
it will be desirable to examine the impact of assumed population size on simulation outcome. It
bears noting that because of the quantized nature of infection (in the model – as in the real world
– one doesn’t have 0.25 infectives) and non-linear interactions within the model, it should not be
assumed that model results will scale linearly with population size and structure.
Due to the potentially significant impact of network structure on infection transmission dy-
namics, we need to specify a particular network structure within which we will examine the model
behavior (measures of TB spread in particular). While an investigation of the underling TB-relevant
contact network structure extant in Saskatchewan is an important line of research, it lies outside
the scope of this thesis. For this set of scenarios, we assume the underlying network structure for
the population is scale-free since this gives the highest level of heterogeneity in terms of connections
compared with other assumptions of the network types in our model.
Assuming a scale-free network, we are with in some sense making a “worst-case” assumption
regarding the potential for TB spread given the higher degree of the variability of this spread. In
addition, the contact tracing program is disabled in these scenarios. Cumulative incidence cases for
a period of 20 years is used to measure the impact of population size on TB spread. The fraction of
the Registered Indian in the community is maintained as 90% in all the realizations. The population
size for each scenario is 5,000, 10,000, 15,000 and 20,000 respectively. Each scenario is simulated
for 30 realizations, each associated with a different random seed, and the results of the simulation
is demonstrated in Table 5.4.
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Table 5.4: Scenarios Regarding Population Size within Scale-free Network without Contact
Tracing Investigation
Cumulative Incidence Cases (Active TB)
Population Size Mean Max Min Std. Deviation Coefficient of Variation(C.V.)
5,000 136.74 263 67 49.50 0.362
10,000 272.81 388 162 65.25 0.239
15,000 423.81 658 293 76.33 0.180
20,000 535.63 736 389 97.34 0.182
Figure 5.7 shows the mean and standard deviation for scenarios regarding different population
size. Within the range examined, when the simulated population size is scaled by a specific factor,
the mean of the cumulative incidence cases is also scaled by the same coefficient, while the standard
deviation of all the scenarios scales sublinearly.
Figure 5.7: Mean and Standard Deviation for Scenarios with Different Population Size
without Contact Tracing
Because the above scenarios have different mean and deviation, in order to compare them in
a meaningful way to determine the impact of population size and have a simulated population
size stable enough to conduct further investigation of contact tracing without heavy fluctuation
that might alter the diffusion behavior, we introduce the coefficient of variation (C.V.), where
C.V. = Std.DeviationMean , to estimate the fluctuation level of incidence cases for scenarios with different
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population size. This ratio cancels the units of the variable, and smaller C.V. indicate that the
measured values are less dispersed. Results shown in Figure 5.8 suggest that the C.V. decreases
for larger population size, and reaches some equilibrium level when the population size is 15,000 or
bigger.
Figure 5.8: Coefficient of Deviation for Scenarios with Different Population Size
In summary, alternating the population size in conjunction with a highly heterogeneous network
structure does not alter the behavior of the system in an unpredictable way. When the simulated
population size increases, the measure of incidence cases becomes more stable with less fluctuation.
Based on these experiments, we posited that having a population size of 15,000 would appear
appropriate enough to capture the characteristics of different scenarios.
5.3.2 User Interface for Scenarios Exploration
An interface was developed within this model to make the simulation easier and efficient for the
user to simulate desired scenarios. Figure 5.9 provides a snapshot of the user interface designed for
customizing the settings for different scenarios, helping to facilitate conducting experiments with
different sets of parameter values. Our user interface provides flexibility in exploring the experi-
ments with respect to different network types (random, small world, scale-free) and network-related
settings (average connections per agent), contact tracing targets (all active TB cases, only infectious
cases, infectious cases and primary TB cases), the criterion to use to set the relative priority for
investigating contacts (ethnicity, age, number of times been reported), the fraction of contacts to
be interviewed(with lower priority contacts never being sought for follow-up), and population size
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Figure 5.9: Contact Tracing Simulation Scenarios Design
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(specified separately for each ethnicity as a fraction of the real population in Saskatchewan).
5.3.3 Baseline Scenarios
Before exploring future policy alternatives, the first set of scenarios is the “Baseline scenarios”
that reflects the status quo without sophisticated and advanced disease control programs. The
parameters for these baseline scenarios maintain their default values. The baseline scenarios, serving
as the reference scenarios, will be compared with a set of customized scenarios regarding different
research questions to evaluated and explore the optimized disease control programs.
Table 5.5: Baseline Scenarios Settings without Contact Tracing Investigation(CTI)
Id Network Type CTI Tracing Target Lost follow-up Tracing Fraction
R0 Random Disabled N/A N/A N/A
W0 Small World Disabled N/A N/A N/A
S0 Scale-free Disabled N/A N/A N/A
In our model, the default settings for baseline scenarios are established as different network
assumptions (random, small world, scale-free network respectively) without contact tracing inves-
tigation program for 20 years’ simulation, seen in Table 5.5. Because of absence of contact tracing
program, active diagnosis and treatment for latent TB infection are not applicable in the baseline
scenarios.
5.3.4 Alternative Scenario Definitions
To explore the alternative futures regarding the 2 questions listed above, a set of experiments will
be designed under each assumption of the underlying network structure with different schemes of
contact tracing. To account for the stochastic variability in results, each scenario consists of 30
realizations with different random seeds, and the time window for each realization is 20 years.
Scenarios Assuming a Random Network
In addition to the baseline scenario under the assumption of a random network, 5 additional
scenarios are simulated in random network with different assumptions with regards to contact
tracing. Question 1 is well examined within this set of experiments. Table 5.6 exhibits the settings
for each scenario. For the “Lost follow-up” column, a value of “30% to 40%” means that contact
tracing is implemented as the data we obtained from TB control in Saskatchewan, while 10%
indiates the standard level of lost follow-up required to achieve published guidelines. All the other
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parameters (i.e. population size, transmission rate, RR) are maintained the same for all the scenarios
in the random network except those mentioned in Table 5.6.
Table 5.6: Scenarios’ Settings under the Assumption of the Random Network with Fraction
of contacts to investigate equal to 90%
Id CTI Tracing Target Lost follow-up CTI Speed
R0 Disabled N/A N/A Normal
R1 Enabled Infectious & Primary TB 30%-40% Normal
R2 Enabled Infectious & Primary TB 10% Normal
R3 Enabled Infectious TB 30%-40% Normal
R4 Enabled Infectious TB 10% Normal
R5 Enabled Infectious & Primary TB 10% Faster(within 30 days)
R6 Enabled Infectious & Primary TB 30%-40% Faster(within 30 days)
The set of scenarios with the random network assumption mainly focus on simulating the impact
of lost follow-up on TB control outcome. R1 and R2 simulate the effect of different contact loss
levels in the contact tracing with investigation targets on both infectious TB and primary TB cases.
In a similar fashion, R3 and R4 also address the issue of loss of contacts, but with the assumption
that the investigation only takes place on infectious TB cases.
In addition, it is worth looking into the outcome by applying the ideal guideline of contact
tracing. So scenario R5 is designed to simulate the optimal contact tracing scheme which is to
investigate 90% of the contacts within 30 days of the diagnosis of an active case. Similarly, scenario
S6 simulates the faster contact tracing with a different follow-up lost level. The “Normal” speed of
the contact tracing is implemented as that we obtained from historical data in 2008 (seen in Table
5.1), while the “Faster” speed of CTI indicates that the contacts are interviewed and tested within
one month on average.
Scenarios Assuming a Small World Network
Under the assumption of a small world network, scenarios regarding the impact of follow-up loss
are also examined. In addition to the small world baseline scenario without contact tracing, 2
more scenarios are designed and simulated with different level of follow-up loss. The settings of the
scenario are depicted in Table 5.7.
Scenarios Assuming a Scale-free Network
In addition to questions with respect to the impact of level of follow-up loss, prioritized contact
tracing (Question 2) is evaluated within the assumption of a scale-free network. Table 5.8 shows
80
Table 5.7: Scenarios’ Settings under the Assumption of the Small World Network with
Fraction of Contacts to Investigate Equal to 90%
Id CTI Tracing Target Lost follow-up Tracing Fraction
W0 Disabled N/A N/A N/A
W1 Enabled Infectious & Primary TB 30%-40% 90%
W2 Enabled Infectious & Primary TB 10% 90%
the parameters of different contact tracing protocols. S0 is the baseline scenario without contact
tracing. S1 and S2 address the issue of follow-up loss when 90% of contacts been investigated
and when both infectious TB and primary TB cases are traced. Scenarios S3, S4, S5, S6, and S7
evaluate the impact of different prioritization schemes (e.g. age, ethnicity, number of times been
reported as a contact, etc.) for contact tracing when we assume a lower fraction of contacts to
investigate (45%). S8 is designed to evaluate fast contact tracing, which is to have 90% contacts
skin tested within 30 days of diagnosis, and it is comparable with S2 where contacts are investigated
at normal speed.
Table 5.8: Scenarios’ Settings under the Assumption of the Scale-free Network
Id CTI Tracing Target Lost follow-up Priority
Tracing
Fraction
S0 Disabled N/A N/A N/A N/A
S1 Enabled Infectious & Primary TB 30%-40% None 90%
S2 Enabled Infectious & Primary TB 10% None 90%
S3 Enabled Infectious & Primary TB 10% None 45%
S4 Enabled Infectious & Primary TB 10% Age 45%
S5 Enabled Infectious & Primary TB 10% Ethnicity 45%
S6 Enabled Infectious & Primary TB 10% Reported Times 45%
S7 Enabled Infectious & Primary TB 10% Age & Ethnicity 45%
S8 Enabled Infectious & Primary TB 10% None 90% Fast
S9 Enabled Infectious TB 30%-40% None 90%
S10 Enabled Infectious TB 10% None 90%
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5.4 Results
5.4.1 Results of Baseline Scenarios
Table 5.9 shows the cumulative incident cases for a period of 20 years under each of the baseline
scenarios in turn, and each scenario is simulated for 30 realizations. Given assumptions of different
underlying network structures for the population, the cumulative incident cases varies significantly.
Scale-free network baseline scenario (S0) gives the highest mean of cumulative incident cases with
large standard deviation, while the lowest mean of the cumulative incident cases among these 3
baseline scenarios is given by the small world baseline scenario (W0), which also gives the lowest
standard deviation. The coefficient of variation (C.V.) is calculated to give a more understandable
estimate of the fluctuation level of our measurement (cumulative incident cases); a smaller C.V.
indicates the measurement values are less dispersed (when considered relative to the size of the
mean) than those with larger C.V.. According to our results based on 30 realizations, the scale-free
network baseline scenario gives the highest C.V., and the lowest C.V. is obtained from the small
world network baseline scenario.
Table 5.9: Average Cumulative Incident Cases for 20 Years in Baseline Scenarios Absence
of Contact Tracing with Implementation of Different Network Structures
Cumulative Incident Cases (Active TB)
Scenario Id Mean Max Min Std. Deviation Coefficient of Variation
R0 250.633 300 199 25.591 0.102
W0 181.433 211 151 14.516 0.08
S0 425.633 614 289 74.659 0.175
The mean prevalence of TB Infection for baseline scenarios are illustrated in Figure 5.10. In
the absence of any contact tracing protocols, the prevalence increases over time in the scale-free
network. In random and small world networks, a declining trend is observed over time, and the
prevalence of TB infection in a small world decreases faster compared with that in a random
network.
5.4.2 Results of Scenarios Assuming a Random Network
Table 5.10 depicts the cumulative incident cases for scenarios with a random network assumption.
Different protocols of contact tracing are assessed especially for the issue regarding follow-up loss.
Based on the mean of the cumulative TB cases, the baseline scenario gives the highest number
of TB cases across all the scenarios. Contact tracing investigation helps reduce the cumulative
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Figure 5.10: Prevalence of TB Infection in the Baseline Scenarios Absence of CTI with
Implementation of Different Networks
TB cases, although the average number of reduced TB cases are quite limited. Targeting both
infectious and primary TB cases, scenarios R1 and R2 show that lowering the loss level of contacts
to 10% can reduce around 18 cases on average. If we restrict the aim of contact tracing to infectious
TB cases only, maintaining a 10% loss of contacts level can prevent roughly 16 active TB cases on
average. Comparing scenario R1 with R3 (which differs only in tracing just infectious cases), the
cumulative incident cases don’t vary much. Scenarios R2 and R4 also doesn’t exhibit significant
difference regarding the average count of cumulative incident cases, despite the broader population
beting traced in R2.
Regarding the ideal protocol for contact tracing, having 90% of the contacts skin tested within
30 days of diagnosis of active TB cases as well as maintaining 10% loss of contacts – scenario R5
– doesn’t show a large difference in cumulative TB cases compared with those of R2 where 90% of
the contacts are tested continuously within a year (rather than within 30 days). While comparing
R1 with R6 (maintaining the same level of follow-up loss 30% to 40% but with difference only in
the speed of CTI), the cumulative TB incident cases decrease dramatically from 231.5 to 223.4 on
average.
Figure 5.11 gives the realization-mean prevalence of TB infection among the population over
time. All trajectories demonstrate the declining trend over time. The prevalence of TB infection
in baseline R0 is above that of other scenarios where contact tracing is enabled. Lower level of
follow-up loss ultimately gives lower prevalence, seen in R2, R4 and R5. Having reverse contact
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Table 5.10: Average Cumulative Incident Cases for 20 Years under the Assumption of
Random Network
Cumulative Incident Cases (Active TB)
Scenario Id Mean Max Min Std. Deviation C.V
R0 250.633 300 199 25.591 0.102
R1 231.5 299 197 29.821 0.129
R2 212.667 262 184 17.149 0.079
R3 232.333 285 187 26.259 0.113
R4 216.933 266 181 21.284 0.098
R5 213.3667 277 167 22.51 0.105
R6 223.4 286 173 24.47 0.11
Figure 5.11: Prevalence of TB infection for Scenarios Regarding Random Network
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tracing (which targets on primary TB cases to assess the source of infection) enabled doesn’t appear
to bring observable difference in TB infection prevalence; the TB infection prevalence in R1 and
R3 are almost overlapped; R2 are R4 are also overlapped in prevalence of TB infection. Since
the objective of investigating primary TB cases is not to lower or reduce the TB incident cases or
prevalence of infection directly, so the contribution given by such reverse contact tracing can’t be
easily assess by these 2 measurements.
In addition, maintaining a faster speed of contact tracing (30 days) and 10% follow-up loss in R5
doesn’t produce significant improvement in prevalence compared with the current speed of contact
tracing (R2). However, under 30% to 40% follow-up loss, faster contact tracing (R6) seems to be
able to lower the prevalence of TB infection while compared with R1.
5.4.3 Results of Scenarios Assuming a Small World Network
Table 5.11 shows the results of small world network scenarios regarding cumulative incident cases.
Regarding the loss of contacts, the mean of cumulative TB cases doesn’t vary dramatically across
scenarios W0, W1 and W2. On average, a small number of active TB cases can be prevented by
having contact tracing enabled (W0 versus W1). The improvement in reducing active TB cases is
also small (only 6 cases) when a 10% of loss of contacts is maintained (see W1 versus W2).
Table 5.11: Average Cumulative Incident Cases for 20 Years under the Assumption of
Small World Network
Cumulative Incident Cases (Active TB)
Scenario Id Mean Max Min Std. Deviation C.V
W0 181.433 211 151 14.516 0.08
W1 174.267 199 136 15.0 0.086
W2 168.867 197 137 16.033 0.095
Figure 5.12 illustrates the TB infection prevalence in the small world network. The differ-
ence in scenarios W0, W1,and W2 are not remarkable, which indicates that increasing the contact
investigation level didn’t make explicit contribution to the prevalence of TB infection.
5.4.4 Results of Scenarios Assuming a Scale-free Network
Under the assumption of a scale-free network, contact tracing strategies varying the level of contact
loss, prioritized contact tracing, and more rapid follow-up are investigated. Figure 5.12 shows the
effect of different contact tracing protocols on the cumulative incident cases in the population. In
absence of any contact investigation activities, the average cumulative incident cases is 425.6 cases
85
Figure 5.12: Average Prevalence of TB infection for Scenarios regarding Small World
Network
– the highest across all the scenarios – and the gap regarding total number of incident cases between
baseline S0 and scenario S1(where contact tracing is enabled with 90% contacts been investigated)
is distinct. Having 90% of contacts investigated, reducing the percentage of loss in contacts from
current level (30% to 40%) to 10% can bring the total incidence numbers down from 311.8 cases
to 279.1 cases on average, seen in scenarios S1 and S2. Similarly, with scope of contact tracing
targeting on infectious TB cases only, lowering the loss of contacts in CTI can result in a much
lower cumulative incident case (from 315 cases to 271.6 cases on average for 20 years, seen in S9
and S10).
While investigating the impact of modifying the target of contact tracing via comparing S1 with
S9 or comparing S2 with S10, the mean of cumulative incident cases decrease.
Results of prioritized contact tracing are shown in scenarios S3 (no priority), S4 (age priority),
S5 (ethnicity priority), S6 (prioritized by number of times been reported as contacts) and S7 (age
and ethnicity priority). In each of these scenarios, 45% of contacts are investigated with 10% loss
in follow-up. Given the relative risk associated with the youngest ages in terms of TB infection,
age prioritized contact tracing – where children under 14 will be targeted first – gives the lowest
cumulative incident cases (283 cases on average). And it is almost the same average level achieved
by investigating 90% of contacts without priority ( 279.1 cases on average in S2). Comparing with
the scenario S3 without priority (318.7 cases), prioritized contact tracing by age (S4), ethnicity
(S5), or a combination of age and ethnicity (S7) gives lower cumulative incident cases on average,
while prioritized contact tracing by number of times a contact has been previously named generates
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higher cumulative incident cases (S6) (363.2 cases). The mixing priority scheme by age and ethnicity
(S7) is better than priority with ethnicity only (S5).
The contribution given by speeding up the contact tracing (improving the speed of contact
tracing to 30 days of diagnosis) can be observed from scenarios S2 and S8. On average, 14 active
TB cases can be prevented in the stylized community over the course of 20 years when much faster
contact tracing is implemented.
Table 5.12: Average Cumulative Incident Cases for 20 Years under the Assumption of
Scale-free Network
Cumulative Incident Cases (Active TB)
Scenario Id Mean Max Min Std. Deviation C.V
S0 425.633 614 289 74.659 0.175
S1 311.767 429 217 49.646 0.159
S2 279.1 392 211 49.682 0.178
S3 318.667 403 207 48.093 0.151
S4 283 364 193 40.403 0.142
S5 302.233 486 194 64.917 0.215
S6 363.2 508 239 70.19 0.193
S7 291 383 190 53.018 0.182
S8 265.5 400 185 44 0.166
S9 315 438 184 49.2 0.156
S10 271.6 387 192 41.57 0.153
Figure 5.13 shows the average prevalence of TB infection in the scale-free network when altering
assumptions regarding follow-up loss and tracing target. Decreasing the contacts loss in the clinical
review stage can eventually reduce the prevalence of TB infection dramatically (seen in S1 and S2),
while restricting the target on infectious TB cases slightly increase the prevalence of TB infection
(seen S1 and S9, or S2 and S10).
Figure 5.14 shows the prevalence of TB infection with respect to different speed of contact trac-
ing. On average, faster contact tracing (S8) didn’t lower the prevalence of TB infection dramatically
compared with normal speed contact tracing (S2).
Figure 5.15 illustrates the impact of prioritized contact tracing on prevalence of TB infection.
Scenarios S0, S2 and S3 shows the impact of assuming that different fractions of contacts enter
the contact tracing system. The gains with respect to TB infection prevalence from tracing of
contacts 45% (S3 vs. S0) is bigger than that from tracing the second 45% of contacts (S2 vs.
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Figure 5.13: Averaged Prevalence of TB infection for Scenarios regarding Lost Follow-up
and Investigation Target in the Scale-free Network
Figure 5.14: Averaged Prevalence of TB infection for Scenarios regarding the Speed of
Contact Tracing in the Scale-free Network
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Figure 5.15: Prevalence of TB infection for Scenarios regarding Prioritized Contact Tracing
in the Scale-free Network
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S3), so diminishing returns is observed, even in the absence of prioritization of contact tracing. In
addition, the prevalence of TB infection in scenarios S4, S5 and S7 fall into an envelop with an
upper boundary given by scenario S3 (45% contacts investigated without priority) and the lower
boundary given by scenario S2(90% contacts traced without priority as well), although scenario
S4 (with pure age prioritization) comes close to the bottom of that boundary. Scenario S6 (where
priority is based on number of times identified as a contact) gives the highest prevalence of TB
infection compared with other prioritized investigation scheme, and it is even higher than contact
tracing without priority (S3).
5.5 Conclusion and Discussion
The role of contact tracing is examined on different contact network topologies with a variety of
combination of investigation priorities, target groups and tracing rates. Given our individual-based
network model representing the contact tracing program for TB control, qualifying the trade-offs
associated with different protocols of contact tracing at an individual level (e.g. prioritized contact
tracing strategies, contacts loss) becomes possible, and such a model can further examine and
enhance our understanding of the current situation so as to aid in the formulation of effective
control strategies.
Starting from different assumptions regarding the underlying network of the population, different
TB diffusion patterns are readily observed. For the baseline assumptions, scale-free networks lead
TB infection to spread aggressively if no actively diagnosis or control programs are implemented,
while the TB infection tends to decrease in random and small world networks even without any
control programs like contact tracing. In terms of cumulative incident cases among the baseline
scenarios, the highest incident cases on average is obtained from the scale-free network; this scenario
also yields the highest sample standard deviation as well, results are consistent with the high
heterogeneity of the scale-free network (where most of the nodes in the network have a limited
number of connections, and only a few have many connections). By contrast, the incident case
counts obtained from the small world and random networks are much lower and possess smaller
sample standard deviation. According to the alternative scenarios measuring the effectiveness of
contact tracing by prioritization or maintaining a lower level of loss in contacts, contact tracing
shows its effectiveness in reducing the prevalent and incident cases explicitly in scale-free network,
while such gains from random network and small world network are not remarkable as those from
scale-free network, with the gains from the small world network being very small. Ultimately
speaking, network architecture is capable of shifting the patterns of TB transmission.
Our first question is to investigate the impact of follow-up loss on the effectiveness of contact
tracing given real contact tracing data collected by Saskatchewan TB control. Assumptions regard-
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ing the true underlying network are made with additional parameters sets with respect to different
contact investigation protocols. Suppose we reach the standard level (having 90% of contact go-
ing through the whole procedure, and most notably without missing the potential clinical review)
versus the current level of contacts loss, and we are interested in understanding how many inci-
dent cases we can prevent and how much we can reduce the prevalence of TB infection on average
by minimizing loss in contacts. According our simulation results of contact tracing program with
different network assumptions, the benefits we obtained while enabling contact tracing investiga-
tion from scale-free and random network are explicit, while those from small world network is not
strongly observable. This suggests to us that it is worth spending extra efforts in bring contacts in,
especially in the clinical review phase, to verify their eligibility for latent TB treatment or diagnosis
of active disease if the true network is either scale-free or random.
Prioritized contact tracing – which gives priority to high risk groups – provide advanced capabil-
ity in managing our limited resources. Our second research question is to investigate effectiveness
of contact tracing in terms of prioritization, and to measure the gains by adhering to prioritized
tracing protocols. Prioritized contact tracing is evaluated within a scale-free network in particular.
With 45% contacts investigated and 10% follow-up loss, we examined contact tracing prioritized
by age, ethnicity, age and ethnicity, count of times the contact has previously been nominated as
a contact. According to the results shown in Table 5.12 and Figure 5.15, the cumulative incident
cases on average listed from lowest to highest is S4 (age priority), S7 (age and ethnicity priority),
S5 (ethnicity priority), and S6 (reported times as contacts). Compared with that from S3 (45%
contacts investigated with no priority and 10% follow-up loss), prioritized protocols of contact trac-
ing – except the one prioritized by the count of times an individual has been reported as a contact
– give a better TB control outcome. In particular, the average cumulative incidences cases from S4
(age priority) is almost the same as that from contact tracing protocol without priority and tracing
twice the number of contacts. This suggests potential TB control strategies, especially from the
cost-effectiveness perspective. We can achieve almost the same level incident cases by tracing 45%
of contacts instead of 90% contacts, which eventually will save resources and money – especially
given limited human resources and funding. Given the prioritization by age, ethnicity or a combi-
nation of these 2 risk factors, we can also achieve a lower level of TB infection prevalence compared
with that from scenario S3 – when no priority is implemented with 45% contacts investigated –
although the prevalence is still higher than that from the scenario S2 when 90% of contacts are
traced without priority.
Under the assumption of a random network, reverse contact tracing (targeting primary TB
cases) is evaluated by adjusting different tracing targets. According the results from R1 versus
R3 and R2 versus R4 (seen in Table 5.6), reverse contact tracing (with objective of finding the
source of infection) doesn’t generate noticeable impact on both average cumulative incident cases
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and TB infection prevalence. If the main target of contact tracing is to lower the prevalence and
incidence rate, then reverse contact tracing is inefficient in preventing TB diffusion. Given the
limited contribution by reverse contact tracing, it can be disabled for effectiveness unless it is
designed for other purposes.
Scenarios regarding faster contact tracing (R7 and S8) in both random and scale-free network are
simulated. Each of these scenarios assumes that contacts finish the procedure of investigation within
30 days. However, the results turns out that faster contact tracing doesn’t contribute strongly to
the TB control outcome (prevalence of TB infection in particular). This results is consistent with
the answer to the same question we examined in the System Dynamics model in Chapter 4. In a
scale-free network, faster contact tracing can bring the cumulative incident cases down to a lower
level by reducing 14 TB cases on average over the 20 year period. Based on the cross-checked results
regarding faster contact tracing, we conclude that, given a random social network of the community,
there may not be a need to speed up the procedure of contact tracing, since it is inefficient from a
cost-effectiveness perspective. While in a scale-free network, there is trade-off when implementing
faster contact tracing. If the major objective is to control the prevalance of infection, faster contact
tracing is not efficient; however, given the goal of reducing the incidence rate, then faster contact
tracing can bring limited contribution to a lower level of cumulative TB cases.
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Chapter 6
Conclusions
6.1 Summary
The objective of this thesis is to compare and contrast representation of TB Transmission dynamics
using System Dynamics modeling and agent-based modeling, so that we can enhance our under-
standing of the dynamics of TB diffusion in terms of casual effects, risk factors, social networks
and evaluation of preventive and treatment strategies. Agent-based models and aggregate models
are compared in the context of TB by setting up a variety of scenarios. Such comparison helps
reveal trade-offs between these two modeling methodologies. In addition, contact tracing strate-
gies are evaluated in a System Dynamics model of TB diffusion by conducting sensitivity analysis.
From an cost-effectiveness view, our model can explore different alternatives when deploying the
contact tracing strategies to optimize the outcome in terms disease control and limited resource
as a whole. Moreover, the impact of explicit incorporation of networks – a closer approximation
to the underlying pathways of transmission – are investigated in an agent-based TB model. Such
a model allows us to conduct comparison with the results of the aggregate models while charac-
tering the disease transition. In addition, our capacity to perform simulations of contact tracing
within social network structures provides extra support in estimating the efficiency of ongoing and
alternative control policies and enriches our understanding of disease transmission with respect to
network topologies. Such epidemiological models can assist in sorting alternatives and optimizing
TB prevention and control programs.
6.2 Deliverables of the Research Work
The deliverables of the thesis work include:
• An agent-based TB model with smoking impact, oriented towards exploring pros and cons
of the aggregate modeling and agent-based modeling methodologies in the course of TB
transmission.
• An aggregate System Dynamics TB model with respect to contact tracing investigation in a
small community of Canadian province of Saskatchewan.
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• An network-based TB model oriented towards investigating the impact of contact tracing
timing, breadth and prioritization strategies at an individual level to explore the optimal
health policies and preventions in TB control.
6.3 Thesis Contribution
The main contribution of this thesis are:
• Understanding of pros and cons of both aggregate modeling and agent-based modeling method-
ologies under the context of TB transmission. This study has investigated the impact of dif-
ferent representations of BCG vaccine, reactivation and network on TB transmission in these
2 models. Different results generated from these 2 models enrich our understanding about
different methodologies and the cost in terms of model development and extension.
• Through simulating contact tracing procedure in a System Dynamics model, the efficiency
of contact tracing program in a small community of Saskatchewan has been investigated.
Regarding the question about how many contacts we should trace, our model depicts dimin-
ishing returns in terms of incidence rate and prevalence when the fraction of contacts has
been investigated goes up. In addition, we also study the speed of contact tracing as another
indicator of the efficiency of contact tracing; scenarios with different speed settings suggest
that the speed doesn’t contribute dramatically to the TB infection prevalence or incidence
rate; nevertheless, contact tracing plays a role in maintaining a lower prevalence and incident
level.
• The third model has extended an existing, well–calibrated mathematical model of TB Dy-
namics for Saskatchewan population to an network-based model, supporting our examination
of more detailed features regarding efficiency of contact tracing and the impact of social net-
work on TB transmission. Given different assumption of the underlying social network of the
population, we have investigated issues of follow-up loss of contacts, speed of contact tracing
and different targets of contact tracing. Given the assumptions regarding the population
network, we re-examined the same questions which we explored in the System Dynamics TB
transmission model with contact tracing to cross-verify our findings. Results of our simulation
suggests that the efficiency of contact tracing varies greatly given different network structure;
network architecture alters the dynamic patterns of TB diffusion which eventually affects the
contact tracing. Some preliminary results reveals that the speed of contact tracing doesn’t
contribute dramatically in reducing the burden of TB, while the fraction of contacts brought
into contact tracing programs plays an important role, the contribution in terms of reducing
the cumulative incident case and prevalence is distinct when the underlying social network
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of the population is assumed to be scale-free. The contribution of prioritized contact tracing
given the assumption of a scale-free network is also remarkable, which should be emphasized in
practice especially from a cost-effectiveness view. Follow-up loss in contacts is also examined,
and its efficiency varies from different network.
6.4 Future Work
The agent-based model in Chapter 3 can be extended by implementing dynamic network (rather
than static network) to gain insights into how TB transmission is affected by network dynamics. A
customized network representing preferential attachment (regarding ethnicity, age or other factors)
could be developed to more accurately address the contact mixing patterns instead of using a
random mixing network.
Given the System Dynamcis model in Chapter 4, risk factors (e.g. age, ethnicity) of TB tran-
mission and sophisticated mixing patterns should be addressed to more accurately capture TB
dynamics in community 1.
Based on the simulation studies in Chapter 5, more simulations should be conducted in conjunc-
tion with statistical analysis to further verify the preliminary findings. Since the presented outcome
are based on a limited set of realizations (30 runs per scenario). Robustness of our findings under
different settings (e.g. disease parameters, control strategies parameters) need to be examined fur-
ther to confirm such differences are not simply the results of chance. Our measurements regarding
the scenarios are the average values of either cumulative incidence cases or TB prevalence across
realizations. Further statistically analysis needs to be undertaken to estimate the reliability of our
simulation results. For example, Student’s t-test can help examine whether the mean from each
scenario is statistically different.
Moreover, scenarios regarding different mean times of contact tracing should be simulated to
gain insights into the sensitivity of TB control outcome on the speed of contact tracing. Faster
contact tracing is only examined within random and scale-free networks, and it doesn’t produce
significant contribution in both cumulative incident cases and prevalence of TB infection. Similar
scenarios should also be examined within a small world network. Insights into the impact of faster
contact tracing is very important, given the current objective of contact tracing in Saskatchewan
is to examine 95% of the contacts within 30 days of diagnosis of an active TB case. To that end, it
would be relatively straightforward to examine the impact of assuming different speeds of contact
tracing (rather than just the two levels of delay examined here).
We only employ 2 measurements (average cumulative incident cases and TB prevalence) when
assessing effectiveness of contact tracing in our agent-based model; additional measurements or
criteria can be included to further evaluate contact tracing efficiency from different angles. In addi-
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tion, we extend the existing calibrated model by adding contact tracing procedure which might alter
the dynamics of the original model. Futher calibration work is needed to verify that our enriched
TB model with contact tracing can reproduce the historical patterns among the Saskatchewan
communities.
In addition to the scenarios we examined in the agent-based TB model with contact tracing,
there are more opportunities to more accurately address TB control given our implementation at
an individual level in agent-based model, e.g. targeted BCG vaccination, waning BCG and waning
TLTBI. Waning of protection given by latent TB treatment or vaccination can be implemented
with dependency on the number of years that have elapsed since prophylaxis or BCG instead of
assuming a static averaged rate per year (as is currently assumed).
Another useful avenue of future work is to capture more details of the mobility at the individual
level in the agent-based model with contact tracing. For example, our model currently assumes that
the network of the population is a more static one, where the network is altered only by birth and
death. A more realistic model could have heterogeneous individuals with different levels of mobility
and implement disease transmission via dynamic contact instead of static connections. Another
opportunity employing mobility of individuals is to bring breaking and forming of relationship into
the static network. However, data regarding the mobility of people living in a typical First Nations
community in Saskatchewan is quite limited. Although dynamics of mobility can introduce more
realistic scenarios, we should be cautious that it might undermine the reliability of the results due
to additional assumptions about people’s contact pattern, in particular contact patterns of First
Nations people in Saskatchewan.
Since the built-in function in Anylogic is applied when implementing the network structure,
different random seeds will generate different network in each realization, an further improvement we
can do in the future on the agent-based model in Chapter 5 is to initialize one network using a fixed
random seed, then run different contact tracing protocols on the same network, like pairwise scheme
to remove the noise or bias introduced by different network generated each time. Comparison based
on pairwise schemes can introduce extra robustness of our simulations.
A further line of work could lend insight into the structure of the underlying contact network,
which can be accomplished by comparing characteristics (degree distribution, degree of locality)
in the TB control contact tracing network with the same characteristics in the simulated contact
tracing network that emerges from the simulation model. Given the large volume of simulation
results regarding the network in Chapter 5, the simulated contact tracing network data can be
analyzed and compared with the true network data collected by Saskatchewan TB control. Such
comparison might help us identify the distinguishing trademarks of TB spread on different network
structure, and it might provide insight into true network or disease parameters, which can be
important when deciding and selecting the most desirable protocol for contact tracing.
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